Presentations: Leipzig Interventional Course – interdisciplinary global platform for endovascular interventions

Room 1 - Main Arena 1

22 events

Tuesday, January 30th: 8:00 - 9:30, Room 1 - Main Arena 1

SYMPOSIUM: Present and future clinical use for vascular mimetic stents

supported with an educational grant from Abbott Vascular

Moderator:

Dierk Scheinert

Panel:

Enrique San Norberto-García, Jörg Teßarek, Peter Goverde
1. 08:00 - 08:07
  
  2-year data Supera popliteal real world
2. 08:07 - 08:14
  
  Supera in popliteal aneursym
3. 08:14 - 08:45
  
  Live case transmission from Leipzig
4. 08:45 - 08:52
  
  Preliminary 6-month results of VMI CFA trial
5. 08:52 - 08:59
  
  NEW DAWN: 1-year results of the combination DCBs and Supera stent for the treatment of long femoropoliteal lesions
6. 08:59 - 09:30
  
  Live case transmission from Leipzig
Tuesday, January 30th: 9:30 - 11:00, Room 1 - Main Arena 1

Latest results with new technologies for femoropopliteal obstructions: drug-eluting devices, atherectomy and new implants

Moderator:

Dierk Scheinert

Panel:

Marianne Brodmann, Thomas Zeller, Steven Kum, Wei Guo
1. 09:30 - 09:35
  
  EFFPAC–RCT: Final 6-months results with the Luminor DCB in femoropopliteal lesions
2. 09:35 - 09:40
  
  ILLUMENATE EU RCT: 2-year results with the Stellarex DCB in femoropopliteal lesions
3. 09:40 - 09:45
  
  FIRST TIME DATA RELEASE: CONSEQUENT RCT: 2-year results with the SeQuent Please OTW DCB
4. 09:45 - 09:50
  
  FIRST TIME DATA RELEASE: IN.PACT Japan RCT of DCB vs. PTA: 2-year results
5. 09:50 - 09:55
  
  FIRST TIME DATA RELEASE: ILLUMENATE GLOBAL: 2-year results of the Stellarex DCB in femoropoliteal lesions
6. 09:55 - 10:00
  
  DANCE trial (ATX and PTA groups) – 2-year results
7. 10:00 - 10:05
  
  Long term durability of DCB treatment in the SFA: 4-year results of the IN.PACT SFA study
8. 10:05 - 10:10
  
  Outcomes of DCB use in real-world patients: 2-year results from the IN.PACT global registry
9. 10:10 - 10:15
  
  FIRST TIME DATA RELEASE: LUTONIX long lesion study: 2-year outcomes
10. 10:15 - 10:20
  
  FIRST TIME DATA RELEASE: COMPARE-Pilot RCT: 1-year results of a randomised comparison of RANGER DCB vs. IN.PACT DCB in complex SFA lesions
11. 10:20 - 10:25
  
  FIRST TIME DATA RELEASE: Outcomes of DCB use in femoropopliteal lesions of patients with CLI (RCC4/5): Subgroup analysis of IN.PACT global study
12. PROMISE AND LIMITATIONS OF DCB – WHAT HAVE WE LEARNED?
13. 10:25 - 10:30
  
  DCB from a preclinical perspective: The relevance of paclitaxel dose and coating integrity
14. 10:30 - 10:35
  
  DCB from a clinical perspective: What is proven and where are the open questions and limitations?
15. 10:35 - 10:40
  
  Panel discussion
16. 10:40 - 10:45
  
  Update on the TOBA studies in the femoropopliteal arteries
17. 10:45 - 10:50
  
  FIRST TIME DATA RELEASE: LOCOMOTIVE All Comers Study with the VascuFlex Multi-LOC spot stenting device: 12-month results
18. 10:50 - 10:55
  
  FIRST TIME DATA RELEASE: 1-year results from the MIMICS-2 Study; US, German, and Japanese experience with the BioMimics 3D stent
19. 10:55 - 11:00
  
  Discussion and conclusion
Tuesday, January 30th: 11:00 - 12:30, Room 1 - Main Arena 1

SYMPOSIUM: Patient first: “Leave the right thing behind”. Debating evidence to provide the answers

supported with an educational grant from COOK Medical

Moderator:

Iris Baumgartner-Peuker

Panel:

Thomas Zeller, Fabrizio Fanelli, Aloke Finn, Marc Bosiers
1. 11:00 - 11:05
  
  Introduction
2. 11:05 - 11:13
  
  XPEDITE study
3. 11:13 - 11:21
  
  DCB + BMS is not a DES
4. 11:21 - 11:41
  
  Live case transmission from Leipzig
5. 11:41 - 11:49
  
  Understanding restenosis in the SFA
6. 11:49 - 11:57
  
  First results of the ZILVERPASS study
7. 11:57 - 12:17
  
  Live case transmission from Jena
8. 12:17 - 12:25
  
  The importance of scientific evidence
9. 12:25 - 12:30
  
  Summing up on symposium discussion and debate
Tuesday, January 30th: 12:30 - 13:30, Room 1 - Main Arena 1

Lunch
Tuesday, January 30th: 13:30 - 15:00, Room 1 - Main Arena 1

Leave nothing behind 2.0: Combination therapy to advance SFA treatment strategy

supported with an educational grant from Medtronic

Moderator:

Dierk Scheinert

Panel:

Krishna Rocha-Singh, Wei Guo
1. 13:30 - 13:35
  
  Introduction
2. 13:35 - 13:45
  
  SFA disease management: Are the longterm outcomes with IN.PACT DCB changing the peripheral landscape?
3. 13:45 - 14:05
  
  Live case transmission from New York
4. 14:05 - 14:15
  
  Dose matters: Understanding the science behind DCB outcomes
5. 14:15 - 14:25
  
  From Chocolate to Hawk: Vessel preparation for improved outcomes
6. 14:25 - 14:45
  
  Live case transmission from Cotignola
7. 14:45 - 15:00
  
  Discussion and conclusion
Tuesday, January 30th: 15:00 - 16:30, Room 1 - Main Arena 1

SYMPOSIUM: Going further with drug eluting technology in peripheral arterial disease: From SFA to below the knee challenges.

supported with an educational grant from Boston Scientific

Moderator:

Dierk Scheinert

Panel:

Marc Sapoval, Hans van Overhagen, Jihad Mustapha
1. 15:00 - 15:03
  
  Opening and learning objectives
2. 15:03 - 15:10
  
  Current data and performance of drug eluting technology in SFA
3. 15:10 - 15:17
  
  BTK intervention with drug coated balloons. Past lessons and future exploration
4. 15:17 - 15:47
  
  Live case transmission from Leipzig
5. 15:47 - 15:54
  
  Drug eluting stents in BTK intervention – a review
6. 15:54 - 16:01
  
  Next steps in drug eluting stent for BTK intervention
7. 16:01 - 16:08
  
  Clinical targets and patient outcome goals in BTK intervention
8. 16:08 - 16:25
  
  Panel discussion
9. 16:25 - 16:30
  
  Closing remarks
Tuesday, January 30th: 16:30 - 18:00, Room 1 - Main Arena 1

Advanced solutions for calcified lesions and CTOs

Moderator:

Ramon Varcoe, Thomas Zeller

Panel:

Richard Heuser, Gunnar Tepe, Andrew Holden, Krishna Rocha-Singh, Darren Schneider, Arne Schwindt
1. 16:30 - 16:36
  
  Vessel preparation: What does it mean and what are the current tools (PTA, DA and scoring balloons)?
2. 16:36 - 16:41
  
  Impact of chronic total occlusion on outcomes: IN.PACT global CTO imaging cohort
3. 16:41 - 17:02
  
  Live case transmission from New York
4. 17:02 - 17:08
  
  Understanding the challenges with measuring calcium in DCB clinical trials
5. 17:08 - 17:14
  
  Vascular calcium: new pre-clinical models and new treatment solutions
6. 17:14 - 17:19
  
  Clinical experience with the Phoenix atherectomy system for complex calcified lesions
7. 17:19 - 17:25
  
  Applications of Lithoplasty for the treatment of calcified lesions
8. 17:25 - 17:30
  
  Shockwave Lithoplasty System treatment of calcified lesions: Intravascular OCT analysis
9. 17:30 - 17:50
  
  Live case transmission from Leipzig
10. 17:50 - 17:55
  
  The “Crack and Pave” technique for highly resistant calcified lesions: Initial results
11. 17:55 - 18:00
  
  Discussion and conclusion
Wednesday, January 31st: 8:00 - 9:30, Room 1 - Main Arena 1

Below-the-knee revascularisation: Current status, challenges, and future outlook

Moderator:

Dierk Scheinert, Peter Schneider

Panel:

Jihad Mustapha, Steven Kum, Kazushi Urasawa, Osamu Iida
1. 08:00 - 08:05
  
  Comprehensive meta-analysis of endovascular versus bypass for critical limb ischemia – is bypass obsolete?
2. 08:05 - 08:10
  
  Three-year outcomes of surgical vs. endovascular revascularisation for critical limb ischemia: The Surgical reconstruction vs. Peripheral INtervention in pAtients with critical limb isCHemia (SPINACH) study
3. 08:10 - 08:17
  
  Retrograde tibial puncture has changed our algorithm for crossing tibial lesions in CLI: How and when to do it?
4. 08:17 - 08:24
  
  Advanced crossing and wiring techniques in BTK vessels
5. 08:24 - 08:51
  
  Live case transmission from Leipzig
6. 08:51 - 08:58
  
  Technical considerations for successful use of DCBs in BTK arteries: Lessons learned from preclinical studies
7. 08:58 - 09:03
  
  Update on the LUTONIX BTK Global Registry: First look at 300 patient interim follow up data
8. 09:03 - 09:10
  
  Patterns of vessel calcification in BTK arteries and implications for vessel preparation and atherectomy
9. 09:10 - 09:15
  
  Update on the Optimize BTK trial (Atherectomy with the CSI atherectomy catheter in combination with DCB in calcified BTK lesions)
10. 09:15 - 09:20
  
  Lithoplasty – also an option for calcified BTK vessels? Update on the Shockwave BTK study
11. 09:20 - 09:25
  
  Update on TOBA below-the-knee
12. 09:25 - 09:30
  
  Adventitial drug therapy below-the-knee: Update on LIMBO and TANGO
Wednesday, January 31st: 9:30 - 11:00, Room 1 - Main Arena 1

Symposium: DCB progress update: science, evidence, and vessel prep algorithms

supported with an educational grant from Spectranetics, a Philips Company

Moderator:

Gunnar Tepe, Sean Lyden

Panel:

Ehrin Armstrong, Simon Bays
1. 09:30 - 09:33
  
  Introduction
2. 09:33 - 09:40
  
  Requirements and specificities of a low-dose DCB: the Stellarex case example
3. 09:40 - 09:47
  
  Stellarex level 1 evidence in common to complex patients
4. 09:47 - 10:07
  
  Live case transmission from Leipzig
5. 10:07 - 10:14
  
  As simple as scoring: Angiosculpt vessel prep and case review
6. 10:14 - 10:21
  
  In-stent-restenosis: new evidence from laser + DCB
7. 10:21 - 10:41
  
  Live case transmission from Leipzig
8. 10:41 - 11:00
  
  Discussion and conclusion
Wednesday, January 31st: 11:00 - 12:30, Room 1 - Main Arena 1

Symposium: Extended indication for the new GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis

supported with an educational grant from Gore & Associates

Moderator:

Mauro Gargiulo

Panel:

Giovanni Torsello, Michele Antonello, Chris Metzger, Michel Reijnen
1. 11:00 - 11:05
  
  Introduction by chairman
2. 11:05 - 11:15
  
  Complexity of iliac occlusive disease, current treatment algorithm, and treatment gaps
3. 11:15 - 11:25
  
  2-year outcomes from the GORE. VIABAHN. VBX Balloon Expandable IDE study
4. 11:25 - 11:40
  
  Recorded case presentation from Arnhem (NL)
5. 11:40 - 11:50
  
  Aortic challenges, quantitative analysis in fenestrated procedures
6. 11:50 - 12:05
  
  Recorded case presentation from Münster
7. 12:05 - 12:30
  
  Discussion and conclusion by chairman
Wednesday, January 31st: 12:30 - 13:30, Room 1 - Main Arena 1

Lunch
Wednesday, January 31st: 13:30 - 15:00, Room 1 - Main Arena 1

Symposium: Lutonix® Drug Coated Balloon – Evidence in SFA, BTK, and AV

supported with an educational grant from C. R. BARD

Moderator:

Dierk Scheinert

Panel:

Aloke Finn, Scott Trerotola, Luis Mariano Palena, Kate Steiner, Martin Banyai
1. 13:30 - 13:35
  
  Introduction
2. 13:35 - 13:45
  
  Are all DCBs the same?
3. 13:45 - 13:55
  
  Treatment of TASC C & D lesions with DCB
4. 13:55 - 14:05
  
  Is DCB treatment right for below-the-knee patients?
5. 14:05 - 14:15
  
  Management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia – a single center experience
6. 14:15 - 14:25
  
  Long term benefit effects of Lutonix 035 DCB
7. 14:25 - 14:35
  
  The role of Lutonix DCB in AV fistula dysfunction management in our practice
8. 14:35 - 14:45
  
  DCB outcomes in real world patients with restenotic AV fistula
9. 14:45 - 15:00
  
  Live case transmission from Leipzig
Wednesday, January 31st: 15:00 - 16:30, Room 1 - Main Arena 1

VIVA@LINC: Facing the future with a look 10 years forward

Moderator:

John Laird, Peter Schneider

Panel:

Dierk Scheinert, Krishna Rocha-Singh, Chris Metzger
1. 15:00 - 15:05
  
  Announcement of the winners of the Vascular Career Award 2017
2. 15:05 - 15:13
  
  Type B aortic dissection: Endovascular grafting will be required in most patients
3. 15:13 - 15:39
  
  Live case transmission from Teaneck
4. 15:39 - 15:47
  
  Drug-coated balloons: Will be used in every vascular bed, yes or no?
5. 15:47 - 15:55
  
  The breakthrough in complex tibial and pedal revascularisation will be….
6. 15:55 - 16:22
  
  Live case transmission from Teaneck
7. 16:22 - 16:30
  
  We will have agreed upon indications for repair of asymptomatic carotid atenosis, yes or no?
Wednesday, January 31st: 16:30 - 18:00, Room 1 - Main Arena 1

The last frontiers: Endovascular therapy of the common femoral artery and the popliteal segment

Moderator:

Marc Bosiers, Lawrence Garcia

Panel:

Chris Metzger, Ulrich Beschorner, Ralph-Ingo Rückert, Martin Malina, Darren Schneider
1. 16:30 - 16:37
  
  Is it now time for endovascular techniques to conquer the CFA?
2. 16:37 - 16:42
  
  Complex stenting of the common femoral artery
3. 16:42 - 16:47
  
  Recanalisation of femoral bifurcations using the Culotte stent technique
4. 16:47 - 16:52
  
  The VMI-CFA study: A physician-initiated study investigating the Supera stent in the common femoral artery (preliminary 6-month results)
5. 16:52 - 17:15
  
  Live case transmission from Bad Krozingen
6. 17:15 - 17:20
  
  Drug-eluting treatments of the common femoral artery – the last frontier
7. 17:20 - 17:25
  
  Combined use of directional atherectomy and DCB for the treatment of the CFA: immediate and one-year outcomes
8. 17:25 - 17:50
  
  Live case transmission from Leipzig
9. 17:50 - 17:55
  
  DCB for popliteal artery stenosis: Update from the IN.PACT Flexion trial
10. 17:55 - 18:00
  
  Results from the 100 patients of the prospective TIGRIS Vienna study
Thursday, February 1st: 8:00 - 9:30, Room 1 - Main Arena 1

The last frontiers: Extreme BTK interventions

Moderator:

Peter Schneider, Roberto Ferraresi

Panel:

Hiroyoshi Yokoi, Olaf Bakker, Miguel Montero-Baker, Steven Kum, Antonio Micari
1. 08:00 - 08:20
  
  Live case transmission from Leipzig
2. 08:20 - 08:27
  
  Micro knuckle technique: Quick and easy recanalisation of re-occluded BTK arteries
3. 08:27 - 08:34
  
  DCB for BTK arteries: New technologies and latest data
4. 08:34 - 08:41
  
  Adventitial drug delivery for treatment of infrapopliteal critical limb ischemia
5. 08:41 - 08:48
  
  When is below-the-ankle angioplasty indicated and how to introduce it into your practice?
6. 08:48 - 09:09
  
  Live case transmission from Abano Terme
7. 09:09 - 09:16
  
  Dorsalis pedis artery entrapment: curiosity or clinical issue in CLI patients?
8. 09:16 - 09:23
  
  How to assess procedural success in complex CLI-settings? Initial OMNIA results: unique tool in the assessment and clinical management of CLI
9. 09:23 - 09:30
  
  Angio-perfusion imaging in CLI-patients with pharmacological and catheter-based interventions? Can we predict outcome?
Thursday, February 1st: 9:30 - 11:00, Room 1 - Main Arena 1

Symposium: The role of purely mechanical debulking in thrombus containing lesions in arteries and veins

supported with an educational grant from Straub Medical

Moderator:

Gerard O'Sullivan

Panel:

Bruno Migliara, Miroslav Bulvas, Romaric Loffroy, Steven Kum
1. 09:30 - 09:33
  
  Introduction
2. 09:33 - 09:40
  
  ISR-treatment – The Leipzig experience with purely mechanical debulking
3. 09:40 - 10:00
  
  Live case transmission from Leipzig
4. 10:00 - 10:07
  
  Mechanical debulking in bypass occlusions – very fast and highly effective
5. 10:07 - 10:27
  
  Live case transmission from Leipzig
6. 10:27 - 10:34
  
  Setting up a deep venous service in your hospital
7. 10:34 - 10:41
  
  Our patients with acute proximal DVT – Effective thrombus removal with purely mechanical thrombectomy can lead to better outcomes
8. 10:41 - 11:00
  
  Discussion and conclusion
Thursday, February 1st: 11:00 - 12:30, Room 1 - Main Arena 1

The remaining challenges: Long lesions and in-stent-restenosis (ISR)

Moderator:

George Adams, Dai-Do Do

Panel:

Torsten Fuß, Jos van den Berg, Hans Krankenberg, Sabine Steiner, Chris Metzger
1. 11:00 - 11:06
  
  Endovascular treatment of severe TASC C & D lesion with Gore® Viabahn endoprosthesis
2. 11:06 - 11:11
  
  Comparing endoluminal to open fempop bypasses: Final 2-year results of the SUPER B trial
3. 11:11 - 11:17
  
  2-year results of a novel Bi-Directional SFA stent design: A comparative study of safety and efficacy
4. 11:17 - 11:42
  
  Live case transmission from Leipzig
5. 11:42 - 11:48
  
  The ZILVERPASS study: a randomised study comparing ZILVER PTX stenting with bypass in femoropopliteal lesions (preliminary 12-month results)
6. 11:48 - 11:53
  
  2-year results of the COPA CABANA RCT of DCB vs. PTA for femoropopliteal ISR
7. 11:53 - 11:59
  
  New evidence from Laser + DCB in ISR
8. 11:59 - 12:24
  
  Live case transmission from Bad Krozingen
9. 12:24 - 12:30
  
  “Crush stenting” – an alternative approach to manage occluded femoropopliteal stents
Thursday, February 1st: 12:30 - 13:25, Room 1 - Main Arena 1

Lunch symposium: Live case with Dr. Andrej Schmidt: Options for crossing

supported with a restricted educational grant from COOK Medical

Moderator:

Peter Schneider

Panel:

Roberto Ferraresi, William Loan

live with:

Andrej Schmidt
1. Welcome
2. What you need to know about crossing BTK lesions
3. Live case transmission from Leipzig and panel discussion
4. Panel discussion
Thursday, February 1st: 13:30 - 15:00, Room 1 - Main Arena 1

Glimpse into the future: Pioneering technique to master the remaining challenges in endovascular interventions

Moderator:

William Gray, Andrew Holden

Panel:

Richard Heuser, Aloke Finn, Krishna Rocha-Singh, Tony Das
1. 13:30 - 13:35
  
  Advances in atherectomy: Phoenix atherectomy – why, when, and how?
2. 13:35 - 13:40
  
  Phoenix registry interim data
3. 13:40 - 14:00
  
  Live case transmission from Leipzig
4. 14:00 - 14:06
  
  Polypharmacy and the future of PAD and CLI drug therapy
5. 14:06 - 14:12
  
  Fusion techniques for treatment of peripheral artery interventions
6. 14:12 - 14:18
  
  Percutaneous transvenous prosthetic arterial bypass for long complicated fem-pop occlusions: The PQ Bypass procedure
7. 14:18 - 14:40
  
  Live case transmission from Münster
8. 14:40 - 14:45
  
  Update on the DETOUR I study: 12-month data
9. 14:45 - 14:50
  
  Clinical experience and latest clinical data with the EndoAVF technology
10. 14:50 - 15:00
  
  Recorded case presentation
Thursday, February 1st: 15:00 - 16:30, Room 1 - Main Arena 1

New concepts for AV-shunt revascularisation and central vein stenoses

Moderator:

Andrew Holden, Bart Dolmatch

Panel:

Scott Trerotola, Konstantinos Katsanos, Panagiotis Kitrou, Ayman Al-Sibaie
1. 15:00 - 15:07
  
  How the past leads to the future – A review of AV-shunt treatment options
2. 15:07 - 15:14
  
  Lysis-Assisted Balloon (LAB) thrombectomy. A declotting technique for the treatment of thrombosed arteriovenous dialysis grafts. 5-year experience of 241 procedures
3. 15:14 - 15:42
  
  Live case transmission from Teaneck
4. 15:42 - 15:49
  
  Technical aspects of treating AVF with IN.PACT DCB
5. 15:49 - 15:54
  
  Long term benefit from Lutonix 035 AV IDE trial
6. 15:54 - 15:59
  
  First interim look at the LUTONIX® DCB AV registry
7. 15:59 - 16:04
  
  Update on the IN.PACT AV access trial
8. 16:04 - 16:09
  
  Treatment options for critical hand ischemia: A single center experience
9. 16:09 - 16:19
  
  Live case transmission from Teaneck
10. 16:19 - 16:30
  
  Discussion and conclusion
Thursday, February 1st: 16:30 - 18:00, Room 1 - Main Arena 1

The last frontiers: Extreme Ilio-femoral interventions

Moderator:

Tony Das, Kazushi Urasawa

Panel:

Thomas Rand, Hans Krankenberg, Thomas Heller
1. 16:30 - 16:37
  
  Balloon expandable covered stents in aorta-iliac occlusive disease: Suddenly a crowded space
2. 16:37 - 16:44
  
  Hybrid revascularisation techniques for complex peripheral arterial occlusions
3. 16:44 - 17:12
  
  Live case transmission from Leipzig
4. 17:12 - 17:19
  
  Distal puncture and bidirectional wiring techniques: Key role in the treatment of long femoro-popliteal occlusive disease
5. 17:19 - 17:26
  
  Results of 300 consecutive retrograde recanalisations of complex femoropopliteal or below-the-knee occlusions
6. 17:26 - 17:55
  
  Live case transmission from Bad Krozingen
7. 17:55 - 18:00
  
  Discussion and conclusion
Friday, February 2nd: 9:00 - 13:00, Room 1 - Main Arena 1

Critical issues and pioneering solutions in aortic endografting

Moderator:

Martin Malina, Eric Ducasse

Panel:

Giovanni Torsello, Marc van Sambeek, Thomas Larzon, Piotr Kasprzak, Reza Ghotbi
1. 09:00 - 09:40
  
  Live case transmission from Münster
2. 09:40 - 09:47
  
  A new concept to evaluate decision making factors for the treatment of complex aortic aneurysms
3. 09:47 - 09:54
  
  Evolution of gender-related differences in outcome of EVAR
4. 09:54 - 10:01
  
  Workflow innovation for optimized hybrid OR performance
5. 10:01 - 10:08
  
  The role of 2D and 3D fusion imaging for reconstruction of complex aortic pathologies
6. 10:08 - 10:15
  
  Evolvement of interventional imaging and dose reduction techniques for image guided endovascular treatment of complex aortic pathologies
7. 10:15 - 10:55
  
  Live case transmission from Leipzig
8. 10:55 - 11:02
  
  Branch for IMA in branched EVAR – when and why?
9. 11:02 - 11:09
  
  Connection of a celiac artery to branched stent-graft by retrograde access through SMA
10. 11:09 - 11:16
  
  One case of dissection Type B treated by new technique FIL&FIS (Fusion Images, Laser & Fenestration In Situ)
11. 11:16 - 11:23
  
  All axillary artery approach for repair of complex thoracoabdominal aneurysms
12. 11:23 - 11:30
  
  Endovascular treatment of ruptured thoracoabdominal aneurysms
13. 11:30 - 11:37
  
  Infectious complications of the aorta – how to approach
14. 11:37 - 12:17
  
  Live case transmission from Münster
15. 12:17 - 12:24
  
  Total endovascular aortic arch replacement with chimney/ sandwich techniques
16. 12:24 - 12:31
  
  Staged repair of chronic Type A dissection
17. 12:31 - 12:38
  
  Sandwich-graft technique to preserve both internal iliac arteries in a patient with previous aorto-aortic bypass and external iliac artery occlusion
18. 12:38 - 13:00
  
  Discussion and conclusion

Room 2 - Main Arena 2

21 events

Tuesday, January 30th: 8:00 - 9:30, Room 2 - Main Arena 2

Acute deep vein thrombosis

Moderator:

Stephen Black, Michael Lichtenberg

Panel:

Jörn Dopheide, Christian Erbel
1. 08:00 - 08:10
  
  Pharmacomechanical thrombolysis
2. 08:10 - 08:20
  
  Catheter-directed thrombolysis
3. 08:20 - 08:30
  
  Catheter treatment of DVT: What do the guidelines say?
4. 08:30 - 08:40
  
  The ATTRACT study: View from the U.S. expert
5. 08:40 - 08:50
  
  The ATTRACT study: View of a European expert
6. 08:50 - 09:10
  
  Live case transmission from Zurich
7. 09:10 - 09:30
  
  Live case transmission from Galway
Tuesday, January 30th: 9:30 - 11:00, Room 2 - Main Arena 2

Management of complex aortoliliac disease: Avoiding complications and optimizing outcomes

Moderator:

Lawrence Garcia, Ramon Varcoe

Panel:

Patrice Mwipatayi, Jörn Balzer, Peter Goverde, Chris Metzger
1. 09:30 - 09:36
  
  Endovascular treatment of occlusive aortic disease with abdominal stent grafts
2. 09:36 - 09:42
  
  Contemporary stenting of the abdominal aorta for steno-occlusive disease: new technical developments
3. 09:42 - 09:47
  
  Mid-term outcome of CERAB for aorto-iliac occlusive disease
4. 09:47 - 10:10
  
  Live case transmission from Cotignola
5. 10:10 - 10:16
  
  Experience after 500 endoluminal stent grafts. Devices specific outcome and lessons learned.
6. 10:16 - 10:21
  
  LIFESTREAM™ – First look at the BOLSTER two year follow up data
7. 10:21 - 10:26
  
  Improving the treatment of complex iliac occlusive disease: 24-month results from the VBX FLEX trial show sustained clinical benefits in complex patient subsets
8. 10:26 - 10:54
  
  Live case transmission from Leipzig
9. 10:54 - 11:00
  
  Prevention and management of vascular complications related to transcatheter aortic valve implantation
Tuesday, January 30th: 11:00 - 12:30, Room 2 - Main Arena 2

Venous stenting

Moderator:

Houman Jalaie, Robert Lookstein

Panel:

Michael Lichtenberg, Christian Erbel
1. 11:00 - 11:15
  
  Live case transmission from Zurich
2. 11:15 - 11:30
  
  Live case transmission from Galway
3. 11:30 - 11:40
  
  Clinical results of venous stents
4. 11:40 - 11:50
  
  Clinical results of a dedicated May Thurner stent
5. 11:50 - 12:00
  
  Anticoagulation after stenting for acute deep vein thrombosis
6. 12:00 - 12:15
  
  Live case transmission from Zurich
7. 12:15 - 12:30
  
  Live case transmission from Galway
Tuesday, January 30th: 12:30 - 13:25, Room 2 - Main Arena 2

LUNCH SYMPOSIUM: Vascular protection in patients with peripheral artery disease (PAD): Improving outcomes with dual pathway inhibition – The COMPASS study

supported with an educational grant from Bayer AG

Moderator:

Dierk Scheinert

Panel:

Sebastian Debus, Uwe Zeymer, Rupert Bauersachs
1. 12:30 - 12:35
  
  Opening remarks
2. 12:35 - 12:45
  
  Vascular protection in patients with CAD and PAD: New options
3. 12:45 - 12:55
  
  From registries to clinical trials: impact on guidelines for PAD
4. 12:55 - 13:10
  
  PAD: From post-intervention to the chronic state
5. 13:10 - 13:25
  
  Question and Answer
Tuesday, January 30th: 13:30 - 15:00, Room 2 - Main Arena 2

SCRUB-IN WITH THE EXPERTS: Endovascular therapy of chronic deep vein obstructions

live from Zurich:

Nils Kucher

live from Galway:

Gerard O'Sullivan

Moderator:

Erin Murphy

Panel:

Yvonne Bausback, Stephen Black, Rick de Graaf, Tim Sebastian, Houman Jalaie
1. FLASH PRESENTATION: Complex iliocaval reconstruction with steel alloy stents
2. FLASH PRESENTATION: Complex iliocaval reconstruction with nitinol stents
3. FLASH PRESENTATION: Endophlebectomy of the common femoral vein
Tuesday, January 30th: 15:00 - 16:30, Room 2 - Main Arena 2

SYMPOSIUM: Nightmares in the cathlab – My worst case and how I solved it

supported with an educational grant from Terumo

Moderator:

Koen Deloose

Panel:

Yann Gouëffic, Andrea Kahlberg
1. 15:00 - 15:05
  
  Introduction
2. 15:05 - 15:25
  
  SFA with distal embolization case
3. 15:25 - 15:45
  
  FP cases
4. 15:45 - 16:05
  
  BTK CLI cases
5. 16:05 - 16:25
  
  CAS cases
6. 16:25 - 16:30
  
  Conclusions
Tuesday, January 30th: 16:30 - 18:00, Room 2 - Main Arena 2

SCRUB-IN WITH THE EXPERTS: Endovascular treatment of central venous stenosis of the chest

live from Zurich:

Nils Kucher

live from Galway:

Gerard O'Sullivan

Moderator:

Robert Lookstein, Stephen Black

Panel:

Ulf Teichgräber, Bart Dolmatch, Raghu Kolluri, Rick de Graaf
1. FLASH PRESENTATION: Drug-coated balloons for the treatment of symptomatic central venous stenosis
2. FLASH PRESENTATION: Interventional techniques for central venous stenosis of the chest
3. FLASH PRESENTATION: COVERA™ – First look at the AVeVA study update for treatment of venous anastomotic lesions in AV grafts and an update on the AVeNEW trial design for outflow stenosis in AV fistula circuits
Wednesday, January 31st: 8:00 - 9:30, Room 2 - Main Arena 2

Endovascular repair for complex iliac aneurysms

Moderator:

Piergiorgio Cao, Armando Lobato

Panel:

Reza Ghotbi, Frank Vermassen, Reinhard Kopp, Daniela Branzan, Thomas Larzon, Olaf Richter
1. 08:00 - 08:06
  
  Iliac artery aneurysms – types and treatment
2. 08:06 - 08:12
  
  The long-term faith of EVAR in patients with ectatic iliac arteries
3. 08:12 - 08:18
  
  Clinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE® Iliac Branch Endoprosthesis (IBE)
4. 08:18 - 08:24
  
  Long-term results of IBD-EVAR: 10 year experience from Leipzig
5. 08:24 - 09:05
  
  Live from Paris: Treatment of an Iliac artery aneurysm with an iliac branched device – Step by step
6. 09:05 - 09:11
  
  The outcome of patients treated with bilateral iliac branched devices for CIA aneurysms
7. 09:11 - 09:17
  
  Is co-existing hypogastric aneurysm a contradiction for the treatment with iliac branched device? Insights from the European PELVIS registry, experience of 9 centers
8. 09:17 - 09:23
  
  A proposed treatment algorithm for iliac aneurysms
9. 09:23 - 09:30
  
  Discussion and conclusion
Wednesday, January 31st: 9:30 - 11:00, Room 2 - Main Arena 2

EVAR – Current status, open questions, and future perspectives

Moderator:

Frank Veith, Frans Moll

Panel:

Sven Seifert, Jean-Pierre Becquemin, Martin Malina, Wei Guo, Roger Greenhalgh, Giovanni Torsello
1. 09:30 - 09:36
  
  Steps to clinical effectiveness and cost effectiveness – Lessons from EVAR 1
2. 09:36 - 09:42
  
  Endovascular repair for patients physically unsuitable for open repair. EVAR 2 15-year results
3. 09:42 - 09:48
  
  RCTs for EVAR: 15 years later are the conclusions obsolete?
4. 09:48 - 09:54
  
  How much open surgery is still required in aortic surgery: A review of 800 aortic aneurysm cases
5. 09:54 - 10:00
  
  Complex-anatomy large aneurysms and why we should consider use of no-treatment and open-surgery strategies more frequently
6. 10:00 - 10:05
  
  Role of gender in TEVAR and EVAR: report from the GREAT registry
7. 10:05 - 10:10
  
  Long-term outcomes of EVAR in female patients: A 5-year analysis from the ENGAGE registry
8. 10:10 - 10:40
  
  Live case transmission from Leipzig
9. 10:40 - 10:45
  
  Ovation endograft: 4-year, real world results from the Ovation European post market registry
10. 10:45 - 10:50
  
  10-year outcome analysis of the ITER registry with the GORE Excluder® endograft for infrarenal abdominal aortic aneurysms
11. 10:50 - 10:55
  
  Predictors of abdominal aortic aneurysm sac enlargment after EVAR; long-term results from the ENGAGE registry
12. 10:55 - 11:00
  
  Discussion
Wednesday, January 31st: 11:00 - 12:30, Room 2 - Main Arena 2

Advanced techniques for juxtarenal aneurysms and challenging neck anatomy

Moderator:

Eric Verhoeven, Jean-Pierre Becquemin

Panel:

Konstantinos Donas, Piotr Kasprzak, Eric Ducasse, Spiridon Botsios
1. 11:00 - 11:06
  
  A new conformable abdominal endovascular device
2. 11:06 - 11:12
  
  Early experience with Ovation Alto™ stent graft: next generation ovation design with an elevated sealing ring
3. 11:12 - 11:18
  
  Custom EVAR (c-EVAR) designs, a step in between standard EVAR and FEVAR devices
4. 11:18 - 11:24
  
  Endovascular fixation of aortic endografts – a solution for short aortic necks?
5. FEVAR VS. CH-EVAR: WHAT IS THE BEST FOR CHALLENGING AORTIC NECKS?
6. 11:24 - 11:30
  
  In favor of Ch-EVAR and Endoanchor-EVAR and how they have emerged as highly useful treatment options for short-neck and juxtarenal AAAs
7. 11:30 - 11:35
  
  In favor of FEVAR and why extended sealing zones with 3 and 4 fenestrations are better than standard double fenestration
8. 11:35 - 12:03
  
  Live from Münster: Chimney EVAR for short aortic neck pathology – Step by step
9. 12:03 - 12:09
  
  Two year comparison of fenestrated and branch grafts vs. parallel grafts for the treatment of juxtarenal and thoracoabdominal aneurysms at a single center
10. 12:09 - 12:15
  
  Evaluating the optimal combination of aortic endografts and chimney devices in the treatment of complex aneuysms: insights from the Pericles registry
11. 12:15 - 12:21
  
  First clinical experience with a new balloon-expandable stent graft: Potential advantages for side branch reconstruction during EVAR of complex pathologies
12. 12:21 - 12:27
  
  ChEVAS Nellix with chimneys: What we've learned from a single center study
13. 12:27 - 12:30
  
  Discussion and conclusion
Wednesday, January 31st: 12:30 - 13:30, Room 2 - Main Arena 2

LUNCH SYMPOSIUM: Advancing EVAR: Access more AAA patients and customise each seal

supported with an educational grant from Endologix

Moderator:

Andrew Holden

Panel:

Eric Verhoeven, Sean Lyden, Martin Storck
1. 12:30 - 12:40
  
  Impact of infrarenal neck diameter on midterm outcome following EVAR: Considerations for repair choice and surveillance
2. 12:40 - 12:50
  
  Finally, an ultra-low profile endograft that is not a tradeoff: Deliverability, patency, and durability of the Ovation® platform
3. 12:50 - 13:00
  
  Why Ovation® may improve EVAR outcomes in women
4. 13:00 - 13:25
  
  Recorded case presentation
5. 13:25 - 13:30
  
  Discussion and conclusion
Wednesday, January 31st: 13:30 - 15:00, Room 2 - Main Arena 2

Acute aortic syndrome: Intramural hematoma, penetrating ulcer, and aortic dissection

Moderator:

Marc van Sambeek, Wei Guo

Panel:

Weiguo Fu, Tilo Kölbel, Wolfgang Ritter
1. 13:30 - 13:36
  
  Intramural hematoma and penetrating ulcers: Natural history and indications for treatment
2. 13:36 - 13:42
  
  Optimal medical treatment for patients with TBADs: Where does it usually go wrong
3. 13:42 - 13:48
  
  Technical considerations for EVAR of Type B aortic dissections
4. 13:48 - 13:54
  
  Despite common believe – oversizing is also justified in TEVAR for Type B aortic dissections
5. 13:54 - 14:20
  
  Live case transmission from Paris
6. 14:20 - 14:26
  
  Asymptomatic collapse of the true lumen in TBAD or “radiologic malperfusion”: Can TEVAR intervention be justified with available evidence?
7. 14:26 - 14:32
  
  Predicting successful aortic remodeling and clinical success of EVAR in Type B aortic dissections – What can we learn from pre-op CT imaging?
8. 14:32 - 14:42
  
  Branched EVAR for a chronic Type B dissection through the false lumen
9. 14:42 - 14:48
  
  First line treatment of acute Type B dissections with the MFM multilayer stent: Preservation of branches and remodelling of the aorta – Does it work?
10. 14:48 - 14:54
  
  Secondary procedures after EVAR for Type B aortic dissections – When and how?
11. 14:54 - 15:00
  
  Adjunctive techniques to induce false lumen thrombosis after TEVAR for TBADs
Wednesday, January 31st: 15:00 - 16:30, Room 2 - Main Arena 2

CX@LINC: aortic endovascular techniques at CX 2017

Moderator:

Roger Greenhalgh

Panel:

Tilo Kölbel, Dittmar Böckler, Andrew Holden
1. 15:00 - 15:05
  
  Welcome by panel
2. 15:05 - 15:15
  
  Video presentation: "Tips and tricks in aortic arch interventions"
3. 15:15 - 15:25
  
  Audience participation and discussion
4. 15:25 - 15:35
  
  Video presentation: “FEVAR case: how to reduce radiation exposure during complex endovascular repair” from S. Haulon presented by
5. 15:35 - 15:45
  
  Audience participation and discussion
6. 15:45 - 15:55
  
  Video presentation: “Technique for delivery of branched grafts during chimney or juxta-renal aortic procedures”
7. 15:55 - 16:05
  
  Audience participation and discussion
8. 16:05 - 16:15
  
  Video presentation: “Tips and tricks for on table imaging to detect EVAR endoleak”
9. 16:15 - 16:30
  
  Audience participation and discussion
Wednesday, January 31st: 16:30 - 18:00, Room 2 - Main Arena 2

Advanced techniques for challenging necks and solutions for endoleaks

Moderator:

Tilo Kölbel, Roberto Chiesa

Panel:

Dittmar Böckler, Jean-Paul de Vries, Reinhard Kopp, Ayman Al-Sibaie, Mauro Gargiulo
1. 16:30 - 16:36
  
  Combined technique (cHFEVAR) (chimney + fenestrated endograft) for complex aneurysm
2. 16:36 - 16:44
  
  Recorded live case: The fenestrated Anaconda endograft
3. 16:44 - 16:50
  
  Adaptation of the peri-renal aorta after placement of a AAA stent graft
4. 16:50 - 17:18
  
  Live case transmission from Münster
5. 17:18 - 17:24
  
  Changes in stent graft apposition and neck morphology post EVAR, CHEVAR, and FEVAR. Are there any differences?
6. 17:24 - 17:30
  
  3– 4x FEVAR vs. standard 2x FEVAR: expected advantages and potential risks
7. 17:30 - 17:36
  
  Routine closure of gutters with liquid polymer solves the Chimney problem and makes them as good as fenestrated grafts
8. 17:36 - 17:42
  
  100% of RAAAs can be treated by EVAR and adjunct techniques as Chimneys and Onyx embolisation – a single center study
9. 17:42 - 17:48
  
  Treatment options of late failures (particularly migration) of EVAS
10. 17:48 - 17:54
  
  Aneurysm sac filling: a new method to treat endoleaks
11. 17:54 - 18:00
  
  Transcaval embolisation of Type 2 Endoleak after EVAR
Thursday, February 1st: 8:00 - 10:15, Room 2 - Main Arena 2

Pioneering techniques for the thoracic aorta and the aortic arch

Moderator:

Vicente Riambau, Frank Veith

Panel:

Weiguo Fu, Frank Criado, Tilo Kölbel, Christoph Nienaber, Marc van Sambeek
1. 08:00 - 08:06
  
  Blunt trauma aortic injury management: lacks in evidence to be overcome
2. 08:06 - 08:11
  
  Technique and early experience using TAG conformable with active control system
3. 08:11 - 08:16
  
  The new Medtronic Valiant Navion TEVAR device: How this new low-profile device can impact TEVAR
4. 08:16 - 08:21
  
  Latest clinical evidence of the Relay thoracic stentgraft
5. 08:21 - 08:26
  
  Clinical experience with a new thoracic stent graft system (Ankura™). Procedural analysis, 30 days and 6-month results in a single center study
6. 08:26 - 08:32
  
  What is current best practice for Type A dissection repair? – Surgical techniques, outcomes, and secondary procedures
7. 08:32 - 08:38
  
  Endovascular repair of post dissection aneurysms involving the arch and thoracoabdominal aorta
8. 08:38 - 08:44
  
  The role of stent grafts in ascending aortic aneurysms
9. 08:44 - 08:50
  
  Aortic arch pathology options: Open, hybrid, fenestration, chimney, or branched stent graft?
10. 08:50 - 08:56
  
  Endografting of the aortic arch: current results and future techniques
11. 08:56 - 09:02
  
  Mid-term results of endovascular arch repair with parallel grafts
12. 09:02 - 09:29
  
  Live case transmission from Leipzig
13. 09:29 - 09:52
  
  Live case transmission from Paris
14. 09:52 - 09:58
  
  Arch repair with the Bolton Medical RelayBranch thoracic stentgraft system: Multi-center experience
15. 09:58 - 10:03
  
  European experience with a thoracic device to treat the arch
16. 10:03 - 10:09
  
  Limitations in patient selection for arch branched devices
17. 10:09 - 10:15
  
  Conversion to open surgery following failed thoracic endovascular repair
Thursday, February 1st: 10:15 - 11:00, Room 2 - Main Arena 2

Focus session: Endovascular fixation of endografts

Moderator:

Giovanni Torsello

Panel:

Vicente Riambau, Jean-Paul de Vries, Colin Bicknell, Giovanni Pratesi, Hence Verhagen
1. 10:15 - 10:39
  
  Live case transmission from Münster
2. 10:39 - 10:46
  
  Mid-term results from ANCHOR: How does this data influence the treatment algorithm for hostile EVAR anatomies
3. 10:46 - 10:53
  
  Failure modes of endoanchors – What have we learned?
4. 10:53 - 11:00
  
  Endoanchors can prevent cranial migration of thoracic endografts: When and how should they be used
Thursday, February 1st: 11:00 - 12:30, Room 2 - Main Arena 2

Symposium: Introducing innovative solutions for the treatment of aortic disease

supported with an educational grant from Gore & Associates

Moderator:

Frank Veith, Christoph Nienaber

Panel:

Giovanni Torsello, Dittmar Böckler, Robert Rhee, Michel Makaroun
1. 11:00 - 11:05
  
  Introduction
2. 11:05 - 11:15
  
  First clinical experience with GORE® TAG® Conformable stent graft with ACTIVE CONTROL system
3. 11:15 - 11:35
  
  Live case transmission from Münster
4. 11:35 - 11:45
  
  Treating challenging aortic anatomies. Are new devices the answer to overcoming current limitations?
5. 11:45 - 11:55
  
  Combining new technologies with a history of proven results in TEVAR
6. 11:55 - 12:05
  
  Expanding EVAR indications with a next generation AAA endograft conforming to 90 degree neck angulations
7. 12:05 - 12:15
  
  New horizon in endovascular care: early experience with an innovative thoracic branched device
8. 12:15 - 12:30
  
  Discussion and conclusion
Thursday, February 1st: 12:30 - 13:30, Room 2 - Main Arena 2

Lunch symposium: Active sac management with Nellix: Addressing the problems of EVAR

supported with an educational grant from Endologix

Moderator:

Eric Verhoeven

Panel:

Andrew Holden, Michel Reijnen, Patrick Berg
1. 12:30 - 12:35
  
  Introduction
2. 12:35 - 12:45
  
  Nellix: Lessons learned from the EVAS Forward Global Registry and the future role of polymer sealing in AAA management
3. 12:45 - 12:55
  
  The DEVASS study: Influence of patient selection on outcomes following EVAS with Nellix within the various IFU
4. 12:55 - 13:05
  
  Reduction in cardiovascular related adverse events following active sac management with Nellix vs. EVAR: Are there biological advantages?
5. 13:05 - 13:25
  
  Recorded case presentation: active aneurysm sac management with Nellix ChEVAS technique.
6. 13:25 - 13:30
  
  Discussion and conclusion
Thursday, February 1st: 13:30 - 14:15, Room 2 - Main Arena 2

Vessel closure devices in large hole access – Patient benefits and best practices

supported with an educational grant from Abbott Vascular

Moderator:

Giovanni Pratesi

Panel:

Darren Schneider, Wouter Lansink
1. 13:30 - 13:35
  
  Introduction
2. 13:35 - 13:43
  
  Perclose ProGlide vs. surgical closure outcomes – Real world evidence
3. 13:43 - 13:51
  
  Sutured mediated closure – technique for closing complex large hole cases
4. 13:51 - 13:59
  
  Tips and predictors of real world outcomes from Italian Club del Percutaneo
5. 13:59 - 14:07
  
  Percutaneous axillary artery access for branch grafting for complex TAAAs and pararenal AAAs: How to do it safely
6. 14:07 - 14:15
  
  Discussion and conclusion
Thursday, February 1st: 14:15 - 15:00, Room 2 - Main Arena 2

Symposium: Strategies and techniques for optimising patient outcomes in complex aortic aneurysm anatomies

supported with an educational grant from Medtronic

Moderator:

Giovanni Torsello

Panel:

Dittmar Böckler, Vicente Riambau
1. 14:15 - 14:21
  
  Treating aortic aneurysms with large necks: What are the considerations?
2. 14:21 - 14:28
  
  Treating very short necks (≥ 4mm <10mm) using the Endurant stent graft + EndoAnchors: 1-year results and current insights
3. 14:28 - 14:35
  
  PROTAGORAS: Standardisation of the chEVAR technique can improve outcomes in patients with short necks
4. 14:35 - 14:42
  
  Tips and techniques for utilising EndoAnchors in TEVAR
5. 14:42 - 15:00
  
  Panel discussion: What factors should be considered when treating complex aortic aneurysm anatomies (EVAR and TEVAR)?
Thursday, February 1st: 15:00 - 18:00, Room 2 - Main Arena 2

Endovascular repair of thoracic and thoracoabdominal aneurysms – technical tips and strategy for prevention of complications

Moderator:

Eric Verhoeven, Michael Borger

Panel:

Patrick Kelly, Michael Jacobs, Sebastian Debus, Marc van Sambeek
1. 15:00 - 15:06
  
  Technique and early experience of a multibranched Off-The-Shelf (OTS) device for treating TAAAs
2. 15:06 - 15:40
  
  Live case transmission from Paris
3. 15:40 - 15:46
  
  How to fix complicated thoracic abdominal anatomy by the retrograde branch technique?
4. 15:46 - 15:52
  
  Bail-out techniques when antegrade catheterisation fails in F/B EVAR (retrograde, snare technique, loop technique, percutaneous retrograde)
5. 15:52 - 15:58
  
  Long-term results of multilayer stent in thoraco-abdominal aneurysms. Aneurysm continue to grow – but is it something in it?
6. 15:58 - 16:04
  
  The SPIDER hybrid graft as novel technique for thoracoabdominal repair
7. 16:04 - 16:10
  
  FEVAR and BEVAR are they cost effective at two years compared to open surgery?
8. 16:10 - 16:16
  
  Spinal cord ischemia after endovascular repair of TAAA with F/B grafts: real incidence and strategies for prevention
9. 16:16 - 16:22
  
  Minimally Invasive Segmental Artery Coil Embolisation (MISACE) and its role in ischemic preconditioning to improve collateral circulation to the spinal cord: From preclinical testing to the PAPA-ARTIS RCT
10. 16:22 - 16:28
  
  Ischemic preconditioning with Minimally Invasive Segmental Artery Coil Embolisation (MISACE) prior to Endovascular TAA repairs: Clinical experience in 50+ patients from Leipzig
11. 16:28 - 17:02
  
  Live case transmission from Leipzig
12. 17:02 - 17:08
  
  Clinical experience with neuromonitoring during open and endo-TAAA repair
13. 17:08 - 17:14
  
  Near infrared spectrometry (NIRS) monitoring of paraspinal muscles to reflect spinal cord ischemia: How does it work and initial results
14. 17:14 - 17:20
  
  Beyond spinal cord ischemia: Complications and pitfalls during endovascular repair in complex TAAA-patients: How to manage and strategies to prevent
15. 17:20 - 17:26
  
  Air emboli as a cause of stroke after TEVAR: What can be done to prevent them?
16. 17:26 - 17:32
  
  Infections of the aorta and major arteries: semi-conservative aproach offers less early morbidity and similar late results as radical open repair
17. 17:32 - 17:38
  
  Open surgical conversion after failure of endovascular aortic repair of thoracic and thoracoabdominal aneurysms
18. 17:38 - 18:00
  
  Discussion and conclusion

Room 3 - Technical Forum

19 events

Tuesday, January 30th: 9:00 - 11:00, Room 3 - Technical Forum

Management of carotid artery disease: Remaining controversies and challenges ahead

Moderator:

Marc van Sambeek, William Gray

Panel:

Carlo Setacci, Stanislaw Bartus, Steve Ramee
1. 09:00 - 09:07
  
  Randomised data in carotid artery stenting: current evidence and future perspectives
2. 09:07 - 09:12
  
  Despite Level 1 and other evidence, the future outlook for carotid stenting is bright
3. 09:12 - 09:19
  
  The future of carotid stenting – Proximal protection and mesh-covered stents are the answer
4. 09:19 - 09:44
  
  Live case transmission from Berlin
5. 09:44 - 09:51
  
  1-year results of a new mesh-covered carotid stent: SCAFFOLD trial
6. 09:51 - 09:58
  
  The CLEAR-ROAD study: a physician-initiated study investigating the RoadSaver stent in carotid lesions (final 12-month results)
7. 09:58 - 10:05
  
  PrOspective multiCentrE study of cArotid artery steNting Using MER Stent – the OCEANUS study
8. 10:05 - 10:12
  
  Comparative analysis of new mesh-covered stent designs using MRI parameters
9. 10:12 - 10:19
  
  Plaque protrusion during carotic artery stenting: risk factors determined by MR plaque imaging
10. 10:19 - 10:26
  
  ROADSTER 2 trial: Transcervical access with reversed flow circuit for proximal protection during CAS. What have we learned so far?
11. 10:26 - 10:33
  
  Transcervical carotid stenting (TECAR) with flow reversal vs. CEA in highly symptomatic patients
12. THE GREAT DEBATE: HOW SHOULD WE HANDLE ASYMPTOMATIC CAROTID STENOSES?
13. 10:33 - 10:40
  
  Carotid repair is best for asymptomatic severe carotid stenosis because medical management alone does not work
14. 10:40 - 10:47
  
  When better NOT to treat asymptomatic carotid stenosis
15. 10:47 - 10:54
  
  ACST-2, over 2500 patients randomised; what do we know?
16. 10:54 - 11:00
  
  Discussion and conclusion
Tuesday, January 30th: 11:00 - 12:30, Room 3 - Technical Forum

The challenge ahead: How to improve acute stroke management

Moderator:

William Gray, Karl-Titus Hoffmann

Panel:

Marco Roffi, Bernhard Reimers
1. 11:00 - 11:07
  
  Periprocedural neurologic complications during CAS: How to manage
2. 11:07 - 11:14
  
  Acute stroke management – What is state of the art?
3. 11:14 - 11:21
  
  Acute stroke treatment: How I do it
4. 11:21 - 11:26
  
  A single centre experience in stroke treatment with EmboTrap II: Technology based on Clot research
5. 11:26 - 11:36
  
  Case reviews
6. 11:36 - 11:43
  
  Reality of stroke management in Germany and how to proceed
7. 11:43 - 11:50
  
  From interventional cardiology to cardio-neurology. A new sub-speciality in the future?
8. 11:50 - 12:16
  
  Live case transmission from Cotignola
9. 12:16 - 12:23
  
  Early results of the PERFORMANCE I study assessing the safety and feasibility of a 3-in-1 carotid stenting sytem with integrated embolic protection
10. 12:23 - 12:30
  
  Experience with bilateral carotid filter protection during percutaneous aortic valve replacement
Tuesday, January 30th: 12:35 - 13:20, Room 3 - Technical Forum

LUNCH SYMPOSIUM: Unmet needs in EVAR: do they exist?

supported with an educational grant from Cardinal Health

Moderator:

Giovanni Torsello

Panel:

Giovanni Pratesi, Jean-Pierre Becquemin
1. 12:35 - 12:52
  
  Unmet needs in EVAR: case and discussion
2. 12:52 - 13:09
  
  Percutaneous technique for EVAR: case and discussion
3. 13:09 - 13:16
  
  Latest clinical results from INCRAFT™ AAA Stent Graft – 5 years of data
4. 13:16 - 13:20
  
  Discussion and conclusion
Tuesday, January 30th: 13:30 - 15:00, Room 3 - Technical Forum

SCRUB-IN WITH THE EXPERTS: Focus on vessel preparation and stenting strategies for complex lesions

partially supported with an educational grant from B. Braun

live from Leipzig:

Andrej Schmidt, Sven Bräunlich

Moderator:

Tony Das, Torsten Fuß

Panel:

Klaus Amendt, Brian DeRubertis, Ulf Teichgräber
1. FLASH PRESENTATION: Vessel preparation prior to DCB or stenting: How to do it
2. 13:45 - 13:50
  
  Clinical benefits of the Vanguard IEP peripheral balloon angioplasty system with integrated embolic protection from the ENTRAP study
3. 13:50 - 14:00
  
  Recorded case presentation: DETOUR procedure overview
4. SPOT STENTING & DCB: IT'S TIME TO UNDRESS THE FULL METAL JACKET
5. FLASH PRESENTATION: Fempop treatment: Long stents vs. short stents
6. FLASH PRESENTATION: Spot stenting with VascuFlex Multi-LOC
7. FLASH PRESENTATION: Combination therapy: DCB & spot stents in fempop lesions
Tuesday, January 30th: 15:00 - 16:30, Room 3 - Technical Forum

SYMPOSIUM: Minimal is optimal in SFA therapy, reducing metal burden

supported with an educational grant from BIOTRONIK

Moderator:

Jos van den Berg

Panel:

Claus Nolte-Ernsting, Lieven Maene
1. 15:00 - 15:05
  
  Introduction by the moderator
2. 15:05 - 15:15
  
  BIOLUX P-III: Passeo-18 Lux all-comers registry: 12-month results for the all-comers cohort
3. 15:15 - 15:25
  
  BIOFLEX PEACE: Pulsar-18 all-comers registry: 12- and 24-month results
4. 15:25 - 15:45
  
  Live case transmission from Berlin
5. 15:45 - 15:55
  
  BIOLUX 4EVER: Combining Passeo-18 Lux DCB and Pulsar-18 BMS: 12-month results of full cohort
6. 15:55 - 16:15
  
  Live case transmission from Leipzig
7. 16:15 - 16:25
  
  BIOTRONIK REACT: REsponse Adapted Combination Therapy: When and where to stent – concept for a pilot study
8. 16:25 - 16:30
  
  Closing by the moderator
Tuesday, January 30th: 16:30 - 18:00, Room 3 - Technical Forum

SCRUB-IN WITH THE EXPERTS: Carotid interventions

live from Leipzig:

Andrej Schmidt

live from Cotignola:

Fausto Castriota, Antonio Micari

Moderator:

Giancarlo Biamino, Gary Ansel

Panel:

Martin Storck, Carlo Setacci, Maria Antonella Ruffino
1. FLASH PRESENTATION: Current consideration for patient oriented revascularisation strategies: CAS vs. CEA vs. medical management
2. FLASH PRESENTATION: How to integrate latest technology to make carotid stenting safer
3. FLASH PRESENTATION: Latest clinical experience with integrated embolic protection during CAS and future directions
4. FLASH PRESENTATION: Combined carotid and coronary revascularisation: Is this a good idea?
Wednesday, January 31st: 8:00 - 9:30, Room 3 - Technical Forum

Focus session: Embolisation therapies and interventional oncology – Part I

Moderator:

Ulf Teichgräber, Michael Moche

Panel:

Thomas J. Vogl, Peter Huppert, Robert Lookstein
1. 08:00 - 08:08
  
  Percutaneous tumor ablation: indications and technical innovations
2. 08:08 - 08:33
  
  Live case transmission from Frankfurt
3. 08:33 - 08:41
  
  Holmium-166 radioembolisation compared to Yttrium-90 radioembolisation
4. 08:41 - 08:49
  
  Radiofrequency ablation versus microwave ablation in HCC and liver metastasis
5. 08:49 - 09:14
  
  Live case transmission from Jena
6. 09:14 - 09:22
  
  Percutaneous after loading therapy in inoperable liver tumors
7. 09:22 - 09:30
  
  Radioembolisation in colorectal liver metastasis
Wednesday, January 31st: 9:30 - 10:15, Room 3 - Technical Forum

SYMPOSIUM: Embolisation and mechanical thrombectomy

supported with an educational grant from Penumbra

Moderator:

Jos van den Berg

Panel:

Lorenzo Paolo Moramarco, Gianmarco de Donato, Stephen D'Souza
1. 09:30 - 09:34
  
  Introduction
2. 09:34 - 09:46
  
  Efficient endoleak treatment with Penumbra large volume coils
3. 09:46 - 09:58
  
  Is the Indigo system a surgeon’s best friend? My experience
4. 09:58 - 10:10
  
  Indigo system: can mechanical thrombectomy be a cost effective solution?
5. 10:10 - 10:15
  
  Discussion and conclusion
Wednesday, January 31st: 10:15 - 11:00, Room 3 - Technical Forum

SYMPOSIUM: Advances in peripheral embolisation therapies

supported with an educational grant from Medtronic

Moderator:

Marcus Treitl

Panel:

Nuno Dias, Hans Lindgren
1. 10:15 - 10:20
  
  Introduction
2. 10:20 - 10:30
  
  Miniaturisation of plugs: How does it advance the embolisation practice? Lecture and case series.
3. 10:30 - 10:40
  
  Advances in coil design: the new 3D detachable fibered coil
4. 10:40 - 10:50
  
  Embolisation of Type II endoleaks with a combination of liquid embolic and microvascular plug
5. 10:50 - 11:00
  
  Discussion and conclusion
Wednesday, January 31st: 11:00 - 12:30, Room 3 - Technical Forum

Focus session: Embolisation therapies and interventional oncology – Part II

Moderator:

Robert Lookstein, Thomas J. Vogl

Panel:

Ralf-Thorsten Hoffmann, Ulf Teichgräber, Boris Radeleff
1. 11:00 - 11:08
  
  Efficacy and safety of chemoembolisation using 40µm Doxorubicin-eluting microshperes in hepatocellular carcinoma
2. 11:08 - 11:33
  
  Live case transmission from Jena
3. 11:33 - 11:41
  
  Chemoembolisation with drug eluting beads preloaded with irinotecan (DEBIRI) liver metastases
4. 11:41 - 11:49
  
  Chemoembolisation using Lipiodol based techinques
5. 11:49 - 12:14
  
  Live case transmission from Frankfurt
6. 12:14 - 12:22
  
  Immuno oncology in regional treatments of metastasis
7. 12:22 - 12:30
  
  Do we need an Angio-CT suite to optimize embolisation procedures?
Wednesday, January 31st: 12:35 - 13:20, Room 3 - Technical Forum

Lunch symposium: Is there a need for flexible stents in patients with venous outflow obstruction?

supported with an educational grant from COOK Medical

Moderator:

Stephen Black

Panel:

Marta Ramírez Ortega, Rick de Graaf
1. 12:35 - 12:40
  
  Introduction
2. 12:40 - 12:55
  
  Helping patients with venous outflow obstruction get back to living in Madrid
3. 12:55 - 13:10
  
  Post thrombotic syndrome: the importance of stent flexibility
4. 13:10 - 13:20
  
  Discussion and conclusion
Wednesday, January 31st: 13:30 - 15:00, Room 3 - Technical Forum

VIVA@LINC: Deep dive into vessel prep: Is it a fad or the optimal pathway forward?

Moderator:

Gary Ansel, Krishna Rocha-Singh

Panel:

Ehrin Armstrong, Tony Das, John Laird, Peter Schneider

live from Teaneck:

John Rundback
1. FLASH PRESENTATION: What can coronary specialists teach the vascular community about the value of vessel prep?
2. FLASH PRESENTATION: Defining vessel prep: how can we set ourselves up for best results?
3. FLASH PRESENTATION: Atherectomy: is vessel preparation for DCB the breakthrough indication?
4. FLASH PRESENTATION: Future algorithm for lower extremity revascularisation: where does vessel prep fit?
Wednesday, January 31st: 15:00 - 16:30, Room 3 - Technical Forum

Focus session: Embolisation therapies and TIPS

Moderator:

Ulf Teichgräber

Panel:

Thomas J. Vogl, Maciej Pech, Walter Wohlgemuth, Boris Radeleff
1. 15:00 - 15:08
  
  Medium and long-term outcome of prostate artery embolisation for patients with benign prostatic hyperplasia
2. 15:08 - 15:29
  
  Live case transmission from Jena
3. 15:29 - 15:37
  
  TIPS Implantation: results and outcome in a liver transplant center
4. 15:37 - 15:45
  
  Value of cone-beam CT to identify anatomic variations for prostate artery embolisation
5. 15:45 - 15:53
  
  Endovascular treatment of arterial-venous malformations: Effectivness and safety
6. 15:53 - 16:14
  
  Live case transmission from Frankfurt
7. 16:14 - 16:22
  
  Interventional treatment of acute and chronic gastrointestinal bleeding
8. 16:22 - 16:30
  
  Beyond gastrointestinal bleeding – Tips and tricks for emergency coil embolisation in various locations
Wednesday, January 31st: 16:30 - 18:00, Room 3 - Technical Forum

Miscellaneous topics: Renal, visceral interventions, and beyond

Moderator:

Robert Lookstein, Iris Baumgartner-Peuker

Panel:

Dai-Do Do, Thomas Heller, Felix Mahfoud
1. 16:30 - 16:36
  
  Renal stenting: Are there still valid indications?
2. 16:36 - 16:42
  
  Update on renal denervation: Latest technical developments and data
3. 16:42 - 17:09
  
  Live case transmission from Leipzig
4. 17:09 - 17:15
  
  Chronic visceral ischemia: tips and tricks
5. 17:15 - 17:21
  
  Large vessel vasculitis – messages for the interventionalist
6. 17:21 - 17:27
  
  Endovascular techniques for visceral artery aneurysm treatment
7. 17:27 - 17:46
  
  Live case transmission from Teaneck
8. 17:46 - 17:52
  
  The SUTTON syndrome: Rare but dangerous
9. 17:52 - 18:00
  
  Interventional options for treatment of pelvic congestion syndrome
Thursday, February 1st: 8:00 - 9:30, Room 3 - Technical Forum

CLI and CTO summit – complex aortoiliac and femoral

live from Bad Krozingen:

Thomas Zeller

live from Leipzig:

Andrej Schmidt

Moderator:

Jörn Balzer, Tony Das

Panel:

Patrice Mwipatayi, Hans Krankenberg, Yasutaka Yamauchi
1. Very complex multi-level bilateral occlusive disease involving both CIA and EIA, right CFA and bilateral SFA occlusions
2. Target stent and anchor balloon: strategies for complex iliac artery chronic total occlusion crossing
3. Reconstruction of occluded iliac artery in Takayaso's arteritis
4. Directional Atherectomy and Anti-Restenotic Theraphy (DAART) in multilevel disease
5. Catheter-directed thrombolysis for acute limb ischemia
Thursday, February 1st: 9:30 - 11:00, Room 3 - Technical Forum

CLI and CTO summit – complex BBT and BTA

live from Bad Krozingen:

Thomas Zeller

live from Abano Terme:

Marco Manzi

Moderator:

Chris Metzger

Panel:

Osamu Iida, Sabine Steiner, Gary Ansel, Daizo Kawasaki
1. Determinants of successful below-the-knee and below-the-ankle intervention: Patient characteristic, anatomical considerations, and advanced techniques
2. Rationale and algorithm for below-the-knee acute gain optimization
3. Efficacy of pedal artery angioplasty toward severity of pedal artery disease: a subanalysis of the rendezvous registry
4. Various strategies for managing the complication during below-the-knee intervention
Thursday, February 1st: 11:00 - 12:30, Room 3 - Technical Forum

CLI and CTO summit – complex CTOs

live from Leipzig:

Andrej Schmidt

live from Abano Terme:

Marco Manzi

Moderator:

Antonio Micari, Ralf Langhoff

Panel:

Masahiko Fujihara, Ramon Varcoe
1. Does anybody remember how to do distal bypasses? When and how?
2. The PIERCE technique for recanalization of heavily calcified arteries in hemodialysis patients
3. Rationale for extravascular ultrasound image-guided revascularisation
4. Critical limb ischemia of the upper extremity: Partial vs. full revascularisation
5. Retrograde approach for lower limb intervention
Thursday, February 1st: 13:30 - 17:00, Room 3 - Technical Forum

Focus session: Pioneering techniques for critical limb ischemia and “no option patients”

live with:

John Rundback, Andrej Schmidt, Marco Manzi, Thomas Zeller

Moderator:

Peter Schneider, Jos van den Berg

Panel:

Marianne Brodmann, Makoto Utsunomiya, Steven Kum
1. Aetiology of CLI and the role of perfusion
2. Zero contrast procedures, myth or reality? Pre-interventional workup with no-contrast MR angiography followed by CO2 angiography
3. Priority registry (poor-risk patients with and without revascularsation therapy for critical limb ischemia)
4. Objective assessment of CLI patients: What about hemodynamic parameters – are they worth anything especially when it comes to end stage no option patients!
5. Change from vessel patency evaluation to evaluation of foot perfusion
6. OMNIA Case Results: Lumee Oxygen measurements representative for CLI wound healing prognosis
7. BTK crossing techniques for the “uncrossable lesion”
8. Immediate and late outcomes of endovascular treatment in Buerger's disease
9. Hybrid arterialization of the venous system in no-option patients with critical limb ischemia
10. The LimFlow procedure – technical details and current clinical experience in Europe
11. Recorded case presentation
12. Perspective on initial LimFlow experience in the US
13. Update on current developments in gene and cell therapy for CLI
Friday, February 2nd: 9:00 - 12:30, Room 3 - Technical Forum

“Great saves and big disasters” – Review of challenging cases and complications

Moderator:

Giancarlo Biamino

Panel:

Steven Kum, Roberto Ferraresi, Hans Krankenberg
1. 09:00 - 09:05
  
  Announcement of the winners of the LINC 2018 poster award
2. 09:05 - 09:45
  
  Live case transmission from Leipzig
3. 09:45 - 09:52
  
  Successful treatment of CLI (1 month thrombosis of the infrarenal aorta, iliac, SFA, tibial arteries) by hybrid approach (CDT, endarterectomy, thrombectomy, balloon angioplasty of BTK and BTA, stenting of the tibial arteries)
4. 09:52 - 09:59
  
  Limb salvage for CLI due to hopeless complex multiple vascular and bypass occlusion
5. 09:59 - 10:06
  
  Full revascularisation of diabetic foot affected by CLI with double retrograde approach, using CO2 as a contrast medium
6. 10:06 - 10:53
  
  Live case transmission from Leipzig
7. 10:53 - 11:00
  
  Percutaneous atherectomy, angioplasty, and stenting at the common femoral artery bifurcation
8. 11:00 - 12:30
  
  Live case transmission from Leipzig

Room 4 - Discussion Forum

11 events

Tuesday, January 30th: 12:30 - 13:30, Room 4 - Discussion Forum

My selection of guidewire and support catheter for complex BTK procedures

supported with an educational grant from Asahi Intecc

Moderator:

Kazushi Urasawa
1. Guide wire selection
2. Guide wire selection
3. Support catheter selection
Tuesday, January 30th: 13:30 - 14:30, Room 4 - Discussion Forum

New GORE® VIABAHN® VBX Balloon Expandable: Expert forum

supported with an educational grant from Gore & Associates

Moderator:

Andrew Holden
1. Advantages of an indication for the GORE® VIABAHN® VBX Balloon Expandable: technical and clinical value in treating aorto-iliac disease
2. Results from the VBX the IDE study and case experience
3. Case experience in aortic disease
4. Discussion
Tuesday, January 30th: 15:00 - 16:00, Room 4 - Discussion Forum

Technical and practical aspects of highend embolo therapy

sponsored by Medtronic

Moderator:

Walter Wohlgemuth, René Müller-Wille
1. Classification of vascular anomalies and its implication on therapies
2. Embolo therapy of peripheral AVMs
3. Treatment of pulmonary AVMs
4. Minimal invasive therapy of endoleaks
5. Discussion
Wednesday, January 31st: 9:30 - 10:30, Room 4 - Discussion Forum

SITE@LINC: An open debate about new concepts and concerns in EVAR/TEVAR Objective: to identify current limitations and propose future directions

Moderator:

Vicente Riambau

Discussant:

Eric Verhoeven, Dittmar Böckler, Andrew Holden, Eric Ducasse
1. TOPICS TO BE DISCUSSED: How do you foresee the real role of the sac-filling concept?
2. TOPICS TO BE DISCUSSED: The post-implant syndrome: is it a real concern to be avoided?
3. TOPICS TO BE DISCUSSED: What will be the best endovascular solution for the arch pathology?
4. TOPICS TO BE DISCUSSEN: Are new adjuvants needed for acute and chronic Type B dissection management
Wednesday, January 31st: 11:00 - 12:00, Room 4 - Discussion Forum

VIVA@LINC: Strategies on the frontline – The year in review: My worst complication of 2017

Moderator:

Peter Schneider

Discussant:

Ehrin Armstrong, Gary Ansel
1. Aortic
2. Carotid
3. Lower extremity
4. Venous
5. This is a case-based session focusing on what we like best ... real cases with challenges and complications that make the experts sweat. In this amphitheater setting, audience participation is encouraged and step-by-step case management is featured and discussed. This round room setting is dedicated to controversial or interactive talk-show-like sessions.
Wednesday, January 31st: 12:35 - 13:20, Room 4 - Discussion Forum

Lunch symposium: Drug-coated balloons for peripheral interventions: a 360° virtual reality experience

supported with an educational grant from Cardionovum

Moderator:

Peter Goverde, Dierk Scheinert
1. 12:35 - 12:38
  
  Introduction
2. 12:38 - 12:45
  
  SAFEPAX®: What’s new in the 3rd generation paclitaxel balloon matrix coating?
3. 12:45 - 12:55
  
  How can we improve treatment of long femoropopliteal lesions with DCB?
4. 12:55 - 13:05
  
  Recorded case presentation: let’s do it together: experience the future of “medicine in virtual reality”
5. 13:05 - 13:15
  
  Recorded case presentation: how can we protect the (CLI) patients to the potential risk of microembolisation?
6. 13:15 - 13:20
  
  Conclusions and closing remarks
Wednesday, January 31st: 14:00 - 15:00, Room 4 - Discussion Forum

Experience the treatment journey of complex cases with innovative vascular solution – Case studies across the spectrum of vascular care

supported with an educational grant from Gore & Associates

Moderator:

Michel Makaroun
1. Treatment of complex thoracic cases
2. Clinical implications of the aortic arch and thoracic curvature remodeling after TEVAR
3. Preserving the hypogastric artery: why, when, and how
Wednesday, January 31st: 15:30 - 16:30, Room 4 - Discussion Forum

CICE@LINC: The role of mechanical thrombectomy in arterial and venous obstructions

Moderator:

Armando Lobato
1. Venous thrombectomy: greater effectiveness with lower risk!
2. Hemodialysis vascular access salvage with mechanical debulking device
3. Mechanical debulking – Is it effective in endograft iliac limb occlusion?
4. Mechanical thrombectomy in peripheral interventions: A multitask and effective tool in a widening scenario. Current evidence and technical tips.
5. Acute and subacute ischemia of the lower limb – Can mechanical debulking replace surgery and thrombolyses?
Thursday, February 1st: 9:00 - 10:00, Room 4 - Discussion Forum

Advanced EVAR therapy with Heli-FX EndoAnchors

sponsored by Medtronic

Moderator:

Giovanni Torsello
1. 09:00 - 09:05
  
  Introduction
2. 09:05 - 09:15
  
  New indication for Heli-FX EndoAnchors with Endurant II: further option in treatment of hostile necks
3. 09:15 - 09:25
  
  EVAR revision setting: how can Heli-FX EndoAnchors improve the outcomes?
4. 09:25 - 09:35
  
  Heli-FX EndoAnchors in the thoracoabdominal aorta
5. 09:35 - 09:45
  
  Heli-FX EndoAnchors during TEVAR: indications and outcomes
6. 09:45 - 10:00
  
  Discussion and conclusion
Thursday, February 1st: 10:00 - 10:45, Room 4 - Discussion Forum

BARD innovations

supported with an educational grant from C. R. BARD

Moderator:

Eric Ducasse

Discussant:

Bart Dolmatch
1. 10:00 - 10:02
  
  Introduction
2. 10:02 - 10:12
  
  Single center patency rates and clinical results of the VENOVO® venous stent in complicated cases
3. 10:12 - 10:22
  
  The role of COVERA™ vascular covered stent in the management of dysfunctioning AV access
4. 10:22 - 10:32
  
  Expanding the treatment options of atherosclerotic lesions in femoral arteries with COVERA PLUS™
5. 10:32 - 10:42
  
  A look at focused force in calcified lesions
6. 10:42 - 10:45
  
  Discussion and conclusion
Thursday, February 1st: 15:00 - 16:00, Room 4 - Discussion Forum

VIVA@LINC: Strategies on the frontline – case-based examinations of contemporary carotid challenges

Moderator:

Chris Metzger

Discussant:

Gary Ansel, Daniela Branzan, William Gray, Tony Das
1. What did I learn from my last case of hyperperfusion syndrome?
2. Management of coincidental disease when treating the carotid bifurcation
3. Technical tips for transcervical approach to carotid stenting (TCAR)
4. Management of carotid in-stent restenosis
5. This is a case-based session focusing on what we like best ... real cases with challenges and complications that make the experts sweat. In this amphitheater setting, audience participation is encouraged and step-by-step case management is featured and discussed. This round room setting is dedicated to controversial or interactive talk-show-like sessions.

Room 5 - Global Expert Exchange

15 events

Tuesday, January 30th: 10:30 - 12:00, Room 5 - Global Expert Exchange

CCT@LINC

Moderator:

Giancarlo Biamino, Kazushi Urasawa

Panel:

Hiroshi Ando, Tatsuya Nakama, Osamu Iida
1. 10:30 - 10:40
  
  Introduction
2. 10:40 - 10:55
  
  Video live and lecture: How to cross below-the-knee CTO
3. 10:55 - 11:10
  
  Video live and lecture: How to cross below-the-ankle CTO
4. 11:10 - 11:25
  
  Video live and lecture: How to cross SFA CTO/Japanese evidences
5. 11:25 - 11:40
  
  Video live and lecture: How to cross SFA CTO/Japanese techniques
6. 11:40 - 12:00
  
  Discussion and conclusion
Tuesday, January 30th: 12:35 - 13:20, Room 5 - Global Expert Exchange

LUNCH SYMPOSIUM: DCB or stent? The latest data to influence your decision

supported with an educational grant from iVascular

Moderator:

Koen Deloose
1. 12:35 - 12:43
  
  Luminor DCB makes it different and favourable in CLI (LUMINOR registry, 12-month data)
2. 12:43 - 12:51
  
  Is there still any space left for DES? (ANGIOLITE BTK trial, 6-month data)
3. 12:51 - 12:58
  
  Discussion: BTK
4. 12:58 - 13:06
  
  Is Luminor DCB the best choice for femoropopliteal lesions? (EFFPAC–RCT, 6-month data)
5. 13:06 - 13:14
  
  Or is the iVolution stent a better alternative? (EVOLUTION study, 12-month data)
6. 13:14 - 13:20
  
  Femoropopliteal arteries discussion
Tuesday, January 30th: 13:30 - 15:00, Room 5 - Global Expert Exchange

Clinical approaches and techniques in the management of CLI diabetic patients

partially supported with an educational grant from Alvimedica

Moderator:

Marco Manzi, Gary Ansel

Panel:

Eric Ducasse, Francesco Liistro
1. 13:30 - 13:38
  
  The specifics of diabetic macroangiopathy: What is different from atherosclerosis and how does it contribute to critical limb ischemia?
2. 13:38 - 13:44
  
  The multidisciplinary approach in BTK intervention in DM patients: the right road to success
3. 13:44 - 13:50
  
  Factors affecting outcome of CLI procedures
4. 13:50 - 13:56
  
  Timing is all in CLI diabetic patients: planning a winning strategy for limb salvage
5. 13:56 - 14:16
  
  Live case transmission from Berlin
6. 14:16 - 14:24
  
  Latest techniques and results in BTK interventions
7. DEBATE ON STUDY RESULTS VS. DAILY PRACTICE IN BTK INTERVENTIONS:
8. 14:24 - 14:30
  
  Use of DCB in BTK – CONTRA
9. 14:30 - 14:36
  
  Use of DCB in BTK – PRO
10. 14:36 - 14:42
  
  Use of DES in BTK – CONTRA
11. 14:42 - 14:48
  
  Use of DES in BTK – PRO
12. 14:48 - 14:54
  
  Is 2018 the right moment to try to harmonize BTK intervention approaches?
13. 14:54 - 15:00
  
  Are the coronary outcomes of BVS relevant to BTK applications?
Tuesday, January 30th: 15:00 - 16:30, Room 5 - Global Expert Exchange

CLI-Therapies-LINCed – Multidisciplinary case studies from centres of excellence

Moderator:

Marianne Brodmann, Steven Kum

Panel:

Osamu Iida, Michiel Schreve
1. MANAGING THE INFECTED WOUND
2. 15:00 - 15:12
  
  How do you prioritize revascularisation vs. treatment of infection – presentation and a case example
3. 15:12 - 15:18
  
  Questions and answers
4. ANGIOSOME DIRECTED THERAPY
5. 15:18 - 15:30
  
  Angiosome concept – myth or truth? Does it make a real difference in “real world” cases? Presentation and a case example
6. 15:30 - 15:36
  
  Questions and answers
7. THE "MOTHER OF ALL CLIs" – THE RUTHERFORD 6 WOUND
8. 15:36 - 15:48
  
  Managing R6 wounds – the utility of multi-vessel revascularisation and inflow strategies – presentation and a case example
9. 15:48 - 15:54
  
  Questions and answers
10. CLI IN DIALYSIS – A SPECIAL BREED OF PATIENTS
11. 15:54 - 16:06
  
  Plantar arch and below-the-ankle angioplasty – who, when, and how? Presentation and a case example
12. 16:06 - 16:12
  
  Questions and answers
13. END STAGE NO OPTION CLI – MAKING SWEET DESSERT OUT OF THE DESERT FOOT
14. 16:12 - 16:24
  
  Percutaneous deep venous arterialisation with the LimFlow procedure – presentation and a case example
15. 16:24 - 16:30
  
  Questions and answers
Wednesday, January 31st: 8:00 - 9:30, Room 5 - Global Expert Exchange

Deep dive session: Lower limb interventions (part I) – Focus on vessel preparation and drug-coated balloons

Moderator:

Tony Das, Iris Baumgartner-Peuker

Panel:

George Adams, Hans Krankenberg
1. 08:00 - 08:15
  
  Live case transmission from Leipzig
2. 08:15 - 08:20
  
  What is vessel preparation and how have the DEFINITIVE LE and DEFINITVE AR results influenced current practice?
3. 08:20 - 08:25
  
  What have we learned so far in the REALITY study?
4. 08:25 - 08:30
  
  Laser in practice: defining the right settings across different lesion morphologies
5. 08:30 - 08:35
  
  The PRELUDE study: PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator® DevicE
6. 08:35 - 08:40
  
  Comparison of particulate embolisation in different DCB formulations
7. 08:40 - 08:45
  
  Real-world experience with a Paclitaxel Coated Balloon for the treatment of atherosclerotic infrainguinal arteries. Twelve-month results of the BIOLUX P-III All Comers Registry in diabetic patients
8. 08:45 - 08:50
  
  12-month results from the IN.PACT DCB in a Chinese population
9. 08:50 - 08:55
  
  12-month results with the ORCHID DCB: The Leipzig experience
10. 08:55 - 09:00
  
  The role of DCB in Korea practice: LUTONIX DCB Korean registry 1-year data in fem-popliteal arteries
11. 09:00 - 09:05
  
  First Report of the SELUTION Trial: 6-month 0utcomes of a Novel Sirolimus Coated DCB Technology Evaluated in SFA
12. 09:05 - 09:10
  
  The LEGDEB registry – 12-month results with the Legflow® DCB in femoropopliteal de novo and restenotic lesions
13. 09:10 - 09:15
  
  Impact of gender on outcomes: Review of the IN.PACT SFA 3-year results
14. 09:15 - 09:20
  
  Drug coated balloons vs. BMS for the treatment of femoropopliteal lesions
15. 09:20 - 09:25
  
  Health economic analysis of DCB use in Belgium: Implications for practice
16. 09:25 - 09:30
  
  Discussion and conclusion
Wednesday, January 31st: 9:30 - 10:45, Room 5 - Global Expert Exchange

JET@LINC

Moderator:

Giancarlo Biamino, Yoshiaki Yokoi, Hiroyoshi Yokoi

Panel:

Kazushi Urasawa, Osamu Iida
1. 09:30 - 09:35
  
  Introduction
2. 09:35 - 09:43
  
  Aorto-Iliac artery disease treated with endovascular therapy (EVT) of stent placement; multicenter prospective registry in Japan: OMOTENASHI
3. 09:43 - 09:51
  
  Peripheral artery CTO crossing in Japan
4. 09:51 - 09:59
  
  Challenges for calcified complex SFA lesion assessed by intravascular ultrasound
5. 09:59 - 10:07
  
  Ideal strategy for long SFA-CTO according to pathological findings
6. 10:07 - 10:15
  
  Optimal endpoint of BTK intervention for wound healing
7. 10:15 - 10:23
  
  Decision making of treatment strategy in patients with CLI, learn from Priority and SPINACH study
8. 10:23 - 10:45
  
  Discussion and conclusion
Wednesday, January 31st: 10:45 - 12:30, Room 5 - Global Expert Exchange

Deep dive session: Lower limb interventions (part II) – Focus on Combination therapies and new implants

Moderator:

Giancarlo Biamino, Krishna Rocha-Singh

Panel:

Hiroyoshi Yokoi
1. 10:45 - 10:50
  
  Clinical plasticity of PLLA – Novel BioResorbable vascular platforms from India
2. 10:50 - 10:55
  
  FIRST TIME DATA RELEASE: Outcomes at 2 years in stented vs. non-stented patients post-DCB: A subanalysis from the IN.PACT Global study
3. 10:55 - 11:00
  
  FIRST TIME DATA RELEASE: Real PTX RCT: 3 year data from a randomized comparison of DCB vs. DES in femoropopliteal lesions
4. 11:00 - 11:30
  
  Live case transmission from Leipzig
5. 11:30 - 11:35
  
  Directional Atherectomy and Anti-Restenotic Therapy (DAART) in multilevel disease
6. 11:35 - 11:40
  
  Combination therapy with atherectomy followed by DCB: 1-year outcomes with Lutonix DCB and 1-year outcomes with IN.PACT DCB
7. 11:40 - 11:45
  
  12-month and preliminary 24-month outcomes of combining a DCB with a modern generation of nitinol stent in femoropopliteal lesions: analysis of the BIOLUX 4 EVER study
8. 11:45 - 11:50
  
  Short-term results of the RAPID Randomised trial of the Legflow® paclitaxel-eluting balloon with supera stenting vs. supera stenting alone for the treatment of intermediate and long superficial femoral artery lesions
9. 11:50 - 11:55
  
  Combination of Supera DCB in revascularisation of long femoropopliteal occlusions. Single center experience
10. 11:55 - 12:00
  
  12-month outcomes in the EVOLUTION study: Investigating the iVolution stent in femoropopliteal lesions
11. 12:00 - 12:05
  
  Impact of Zilver PTX after stent implantation for femoropopliteal lesions for 2-year follow up. How to maximize performance of Zilver PTX
12. 12:05 - 12:10
  
  The clinical comparison of Zilver PTX and Innova for femoropopliteal lesions in Japanese single center
13. 12:10 - 12:15
  
  The Supera stent in retrograde vascular access for SFA ostium treatment: The SUPRA-FAST registry
14. 12:15 - 12:20
  
  Laser and DCB for SFA ISR: follow-up of a single center cohort up to 5 years
15. 12:20 - 12:25
  
  LIBERTY 360: Predictors of 1-year outcomes of endovascular device interventions in patients with symptomatic lower extremity peripheral artery disease
16. 12:25 - 12:30
  
  Discussion and conclusion
Wednesday, January 31st: 12:30 - 13:30, Room 5 - Global Expert Exchange

LUNCH SYMPOSIUM: New options and treatment times with EKOS™ Acoustic Pulse Thrombolysis™

supported with an educational grant from BTG

Moderator:

Nils Kucher

Panel:

Mark J. Garcia, Keith M. Sterling, Nima Hatam
1. 12:30 - 12:35
  
  Introduction
2. 12:35 - 12:50
  
  Access PTS – How do I treat my PTS patients?
3. 12:50 - 13:05
  
  The OPTALYSE PE Trial – Reducing thrombolytic dose and treatment times with EKOS™ in the treatment of pulmonary embolism patients
4. 13:05 - 13:20
  
  The surgeon's perspective on PE
5. 13:20 - 13:30
  
  Discussion and conclusion
Wednesday, January 31st: 13:30 - 14:15, Room 5 - Global Expert Exchange

Expert opinion on deep venous stenting – patient selection, technique, and clinical outcomes

supported with an educational grant from Boston Scientific

Moderator:

Stephen Black

Panel:

Michael Lichtenberg, Olivier Hartung
1. 13:30 - 13:35
  
  Introduction
2. 13:35 - 13:45
  
  Venous stenting experience in Arnsberg
3. 13:45 - 13:55
  
  Venous stenting experience in Modena – video presentation
4. 13:55 - 14:05
  
  Venous stenting experience in Marseille
5. 14:05 - 14:15
  
  Discussion and conclusion
Wednesday, January 31st: 14:15 - 16:00, Room 5 - Global Expert Exchange

DEEP DIVE SESSION: Endovenous therapies – Part I

Moderator:

Nils Kucher, Stephen Black

Panel:

Steven Kum, Rick de Graaf
1. FOCUS ON IVC FILTERS
2. 14:15 - 14:22
  
  Pros and cons of IVC filter implantation: What are the established indications?
3. 14:22 - 14:27
  
  Challenging case: Massive thromboembolism trapped in IVC filter during total hip replacement arthroplasty
4. 14:27 - 14:34
  
  Tips and tricks for challenging and complex IVC filter
5. 14:34 - 14:39
  
  To worry or not to worry with a ruptured inferior vena cava post IVC filter removal
6. FOCUS ON DEEP VEIN RECANALISATION
7. 14:39 - 14:46
  
  CTV vs. MRV for imaging of venous disease
8. 14:46 - 15:01
  
  Recorded case presentation
9. 15:01 - 15:08
  
  Assessing the CFV – do I need to perform an endophlebectomy or not
10. 15:08 - 15:15
  
  Where to include IVUS in optimal venous diagnostic treatment pathway
11. 15:15 - 15:22
  
  Radiation dose in venous procedures how do we actively reduce this
12. 15:22 - 15:29
  
  Is there a place for endovascular therapy of acute venous thrombosis after ATTRACT?
13. 15:29 - 15:36
  
  Single session pharmaco-mechanical venous thrombectomy – how to do it!
14. 15:36 - 15:43
  
  Evidence on mechanical thrombectomy for iliofemoral DVT
15. 15:43 - 15:50
  
  Assessing adequate clot removal after lysis – when are you done and decision making in what stent
16. 15:50 - 16:00
  
  Discussion and conclusion
Wednesday, January 31st: 16:00 - 17:30, Room 5 - Global Expert Exchange

Deep dive session: Endovenous therapies – Part II

Moderator:

Gerard O'Sullivan, Erin Murphy

Panel:

Raghu Kolluri, Matthias Ulrich, Karin Brachmann
1. TOWARDS NEW VENOUS STENT DESIGNS: A DEVICE PARADE
2. 16:00 - 16:05
  
  VIVO EU and VIVO US: experience with the ZILVER VENA stent
3. 16:05 - 16:10
  
  Building clinical evidence: Update on the ABRE study
4. 16:10 - 16:15
  
  VENOVO® Venous stent – Update on the Vernacular trial
5. 16:15 - 16:20
  
  Patency rates and clinical results of the Venovo venous stent in a real world registry
6. 16:20 - 16:25
  
  Patency rates and clinical results of the Veniti VICI stent for the treatment of iliac vein lesion
7. 16:25 - 16:30
  
  The bifurcation stent: Sinus obliqus
8. 16:30 - 16:37
  
  Matching the right venous stent to your patient and their individual anatomy
9. 16:37 - 16:44
  
  How to use anatomical landmarks only to precisely position left common iliac venous stents at the IVC confluence
10. 16:44 - 16:51
  
  Re-intervention in venous stents – causes, identification, and solution
11. FOCUS ON SUPERFICIAL VENOUS DISEASE
12. 16:51 - 16:58
  
  Diagnostic workup prior to ablation therapy of superficial venous disease
13. 16:58 - 17:05
  
  VeClose trial: Cyanoacrylate closure vs. RF ablation 36-month results
14. 17:05 - 17:12
  
  Laser technology: latest developments
15. 17:12 - 17:19
  
  Managing the challenging patient: Ancillary procedures for complex anatomies
16. 17:19 - 17:30
  
  Panel discussion
Thursday, February 1st: 9:00 - 11:00, Room 5 - Global Expert Exchange

Global expert exchange: Selected challenging cases and complications

Moderator:

Giancarlo Biamino, Ramon Varcoe

Panel:

Ulf Teichgräber, Ayman Al-Sibaie
1. 09:00 - 09:15
  
  Venous and AV access
2. 09:00 - 09:05
  
  Application of drug coated balloon angioplasty for pulmonary vein stenosis. Novel approach
3. 09:05 - 09:10
  
  Acute phlegmasia cerulea dolens related to complete subacute occlusion of the entire left LE deep venous system in the setting of typical May-Thurner syndrome
4. 09:10 - 09:15
  
  Pseudoaneurysm after IVC filter removal
5. 09:15 - 09:45
  
  Critical limb ischemia
6. 09:15 - 09:20
  
  Creation of a multidisciplinary limb preservation program improves limb salvage and increases endovascular volume in a tertiary referral center
7. 09:20 - 09:25
  
  Feasibility and outcomes of delay revascularization in patients with PAD and tissue loss
8. 09:25 - 09:30
  
  Management of diabetic foot with toe gangrene and severe arterial disease
9. 09:30 - 09:35
  
  Impact of hemodialysis on outcomes for patients with CLI: Assessment using the WIfI classification
10. 09:35 - 09:40
  
  Hybrid treatment of aortoiliac and femoral occlusion for patients with critical limb ischemia
11. 09:40 - 09:45
  
  Telehealth use in wound care
12. 09:45 - 10:20
  
  Visceral, renal and mesenteric
13. 09:45 - 09:50
  
  Treatment of a pancreaticoduodenal arcade aneurysm with a flow modulator stent
14. 09:50 - 09:55
  
  Persistent sciatic artery aneurysm treated with a use of VIABAHN endoprosthesis
15. 09:55 - 10:00
  
  A case of successfully treated penaile ischimic ulcer by internal pudendal artery plasty in a hemodialysis patient
16. 10:00 - 10:05
  
  Management of spontaneous isolated dissection of the superior mesenteric artery
17. 10:05 - 10:10
  
  Renal denervation in Korea
18. 10:10 - 10:15
  
  Renal thrombectomy and vena stent
19. 10:15 - 11:00
  
  Discussion and conclusion
Thursday, February 1st: 11:00 - 12:30, Room 5 - Global Expert Exchange

Nurse and Technician Forum – Part I

Moderator:

Martin Werner, Lieven Maene
1. MY MOST INTERESTING CASE
2. 11:00 - 11:08
  
  Carotid stenting
3. 11:08 - 11:16
  
  Complex femoropoliteal case
4. 11:16 - 11:24
  
  Endovascular aortic repair
5. 11:24 - 11:32
  
  Infrapopliteal recanalisation
6. 11:32 - 11:45
  
  Discussion
7. ADVANCED TECHNOLOGIES IN PERIPHERAL INTERVENTIONS
8. 11:45 - 11:53
  
  Optical coherence tomography in peripheral interventions
9. 11:53 - 12:01
  
  Radiation protection – from global to local
10. 12:01 - 12:09
  
  Drug eluting balloons: Update
11. 12:09 - 12:17
  
  Drug eluting stents: Update
12. 12:17 - 12:25
  
  Adventitial drug infusion to prevent restenosis
13. 12:25 - 12:30
  
  Discussion
Thursday, February 1st: 12:30 - 13:30, Room 5 - Global Expert Exchange

Lunch symposium: BioMimics 3D®: The importance of Swirling Flow® in treating atherosclerosis and preventing restenosis in femoropopliteal arteries

supported with an educational grant from Veryan

Moderator:

Gary Ansel

Panel:

Timothy Sullivan, Michael Lichtenberg
1. 12:30 - 12:35
  
  Introduction by the moderator
2. 12:35 - 12:45
  
  The science behind Swirling Flow®
3. 12:45 - 12:55
  
  1-year results from the MIMICS-2 study
4. 12:55 - 13:05
  
  Two techniques to limit restenosis – drugs and Swirling Flow®
5. 13:05 - 13:15
  
  BioMimics 3D in my clinical practice
6. 13:15 - 13:30
  
  Discussion
Thursday, February 1st: 13:30 - 15:00, Room 5 - Global Expert Exchange

Nurse and Technician Forum – Part II

Moderator:

Theodosios Bisdas, Oliver Schlager
1. MISCELLANEOUS
2. 13:30 - 13:38
  
  Diagnostic steps in cerebral arterial disease
3. 13:38 - 13:46
  
  Reducing contrast induced renal insufficiency
4. 13:46 - 13:54
  
  Radiation safety
5. 13:54 - 14:02
  
  Stenting or surgery for common femoral artery stenosis
6. 14:02 - 14:10
  
  Venous stenting
7. 14:10 - 14:18
  
  Endoluminal treatment of varicose veins
8. 14:18 - 14:23
  
  Discussion
9. CRITICAL LIMB ISCHEMIA
10. 14:23 - 14:31
  
  Improving CLI care – A multidisciplinary challenge
11. 14:31 - 14:39
  
  Non invasive diagnosis in CLI
12. 14:39 - 14:47
  
  Assessment of microcirculation in CLI
13. 14:47 - 14:55
  
  Cardiovascular disease in CLI patients
14. 14:55 - 15:00
  
  Discussion

Room 6 - Speakers' corner

10 events

Tuesday, January 30th: 12:30 - 13:30, Room 6 - Speakers' corner

Update on clinical trials and new data – PVD/ BTK/ CLI

Moderator:

Jihad Mustapha

Panel:

Miguel Montero-Baker, Steven Kum
1. 12:30 - 12:35
  
  36-month results from the absorb BTK study
2. 12:35 - 12:40
  
  6-month results of real-life use of the latest generation of balloon expandable DES in below-the-knee treatment
3. 12:40 - 12:45
  
  Below-the-knee balloon angioplasty with and without non-selective stem cells infusion in treatment of critical limb ischemia
4. 12:45 - 12:50
  
  Statin therapy and amputation-free survival in CLI patients: insights from the CRITISCH registry
5. 12:50 - 12:55
  
  Peroneal artery angioplasty as a single runoff vessel for foot revascularisation in patients with critical limb ischemia
6. 12:55 - 13:00
  
  Real-world experience with a paclitaxel-coated balloon for the treatment of atherosclerotic infrainguinal arteries. 12-month results of the BIOLUX P-III all comers registry in critical limb ischemia patients
7. 13:00 - 13:05
  
  1-year outcomes of peripheral vascular intervention in critical limb ischemia patients: Sub-analysis of the LIBERTY 360 study
8. 13:05 - 13:10
  
  Update on the BEST-CLI trial
9. 13:10 - 13:15
  
  The relation of 2D perfusion angiography after below-the-knee intervention and wound healing in patients with critical limb ischemia – single center prospective study
10. 13:15 - 13:20
  
  Interim results from the OMNIA study – utilisation of micro oxygen sensors during CLI therapy
11. 13:20 - 13:30
  
  Discussion and conclusion
Tuesday, January 30th: 13:30 - 15:00, Room 6 - Speakers' corner

Update on clinical trials and new data – PVD/ aortoiliac/ femoral

Moderator:

Oliver Schlager

Panel:

Theodosios Bisdas, Marcus Thieme
1. 13:30 - 13:35
  
  Midterm outcome of the covered endovascular reconstruction of the aortic bifurcation (CERAB) technique for aortoiliac occlusive disease
2. 13:35 - 13:40
  
  The BeGraft study: A physician-initiated study investigating the BeGraft peripheral stent graft in the iliac arteries (final 24-month results)
3. 13:40 - 13:45
  
  XTRACT as a potential frontline treatment in peripheral arterial thromboembolism – results from the multicenter PRISM trial
4. 13:45 - 13:50
  
  Impact of patient and lesion characteristics on drug coated balloon angioplasty of the femoro-popliteal artery – pooled analysis of four randomized controlled multicentre trials
5. 13:50 - 13:55
  
  Local and distal ptx effect: pre-clinical results with different DCBs
6. 13:55 - 14:00
  
  Long term results of >200 patients with the Aperto® DCB from the Italian Aperto registry
7. 14:00 - 14:05
  
  Interim report of the BIOFLEX-COF RCT, comparing high vs. low chronic outward force of nitinol stents in the SFA
8. 14:05 - 14:10
  
  A French experience of ambulatory intervention for endovascular treatment of peripheral artery disease: a retrospective study
9. 14:10 - 14:15
  
  A randomised comparison of digital subtraction angiography and kinetic imaging
10. 14:15 - 14:20
  
  The influence of balloon inflation time in femoropopliteal and BTK angioplasty: a systematic review
11. 14:20 - 14:25
  
  Tibial velocities duplex ultrasound characterisation and validity of the ankle-deep femoral artery index in peripheral arterial disease
12. 14:25 - 14:30
  
  Use of Paclitaxel-Coated Luminor® balloon catheter in the superficial femoral and popliteal arteries – the solo DEB registry
13. 14:30 - 14:35
  
  BIOFLEX – PEACE registry 24-month analysis
14. 14:35 - 14:40
  
  The Münster all-comers registry of Eluvia drug-eluting stent: 1-year outcomes
15. 14:40 - 14:45
  
  BATTLE RCT. Bare metal stent vs. drug eluting stent for SFA intermediate lesions. 6-month results
16. 14:45 - 14:50
  
  Interim 30-day analysis from the KANSHAS 1 study of the novel KANSHAS drug coated balloon for treatment of femoropopliteal occlusive disease; a latest first-in-human study
17. 14:50 - 14:55
  
  Peripheral aneurysm coiling using large volume ruby coils: Results from the multicenter ACE registry
18. 14:55 - 15:00
  
  Discussion and conclusion
Tuesday, January 30th: 15:00 - 16:30, Room 6 - Speakers' corner

Update on clinical trials and new data – AV access/ venous/ embolisation/ EVAR

Moderator:

Konstantinos Katsanos

Panel:

Frans Moll, Jan Brunkwall
1. 15:00 - 15:05
  
  ACCESS PTS study: ACCElerated thrombolySiS for Post-Thrombotic Syndrome using the Acoustic Pulse Thrombolysis EkoSonic® Endovascular System – midterm results of a multi-center study.
2. 15:05 - 15:10
  
  Prospective, randomised controlled study of paclitaxel-coated vs. plain balloon angioplasty for the treatment of failing dialysis access
3. 15:10 - 15:15
  
  VasQTM improves functional maturation: Randomised controlled multinational study results
4. 15:15 - 15:20
  
  The Lutonix® global AV registry real world patients with a dysfunctional AV dialysis access – interim 6-month outcomes
5. 15:20 - 15:25
  
  DCB in vascular access – where does it work

Notice

LINC 2018 presentations

Room 1 - Main Arena 1

SYMPOSIUM: Present and future clinical use for vascular mimetic stents

2-year data Supera popliteal real world

Supera in popliteal aneursym

Live case transmission from Leipzig

Preliminary 6-month results of VMI CFA trial

NEW DAWN: 1-year results of the combination DCBs and Supera stent for the treatment of long femoropoliteal lesions

Live case transmission from Leipzig

Latest results with new technologies for femoropopliteal obstructions: drug-eluting devices, atherectomy and new implants

EFFPAC–RCT: Final 6-months results with the Luminor DCB in femoropopliteal lesions

ILLUMENATE EU RCT: 2-year results with the Stellarex DCB in femoropopliteal lesions

FIRST TIME DATA RELEASE: CONSEQUENT RCT: 2-year results with the SeQuent Please OTW DCB

FIRST TIME DATA RELEASE: IN.PACT Japan RCT of DCB vs. PTA: 2-year results

FIRST TIME DATA RELEASE: ILLUMENATE GLOBAL: 2-year results of the Stellarex DCB in femoropoliteal lesions

DANCE trial (ATX and PTA groups) – 2-year results

Long term durability of DCB treatment in the SFA: 4-year results of the IN.PACT SFA study

Outcomes of DCB use in real-world patients: 2-year results from the IN.PACT global registry

FIRST TIME DATA RELEASE: LUTONIX long lesion study: 2-year outcomes

FIRST TIME DATA RELEASE: COMPARE-Pilot RCT: 1-year results of a randomised comparison of RANGER DCB vs. IN.PACT DCB in complex SFA lesions

FIRST TIME DATA RELEASE: Outcomes of DCB use in femoropopliteal lesions of patients with CLI (RCC4/5): Subgroup analysis of IN.PACT global study

PROMISE AND LIMITATIONS OF DCB – WHAT HAVE WE LEARNED?

DCB from a preclinical perspective: The relevance of paclitaxel dose and coating integrity

DCB from a clinical perspective: What is proven and where are the open questions and limitations?

Panel discussion

Update on the TOBA studies in the femoropopliteal arteries

FIRST TIME DATA RELEASE: LOCOMOTIVE All Comers Study with the VascuFlex Multi-LOC spot stenting device: 12-month results

FIRST TIME DATA RELEASE: 1-year results from the MIMICS-2 Study; US, German, and Japanese experience with the BioMimics 3D stent

Discussion and conclusion

SYMPOSIUM: Patient first: “Leave the right thing behind”. Debating evidence to provide the answers

Introduction

XPEDITE study

DCB + BMS is not a DES

Live case transmission from Leipzig

Understanding restenosis in the SFA

First results of the ZILVERPASS study

Live case transmission from Jena

The importance of scientific evidence

Summing up on symposium discussion and debate

Lunch

Leave nothing behind 2.0: Combination therapy to advance SFA treatment strategy

Introduction

SFA disease management: Are the longterm outcomes with IN.PACT DCB changing the peripheral landscape?

Live case transmission from New York

Dose matters: Understanding the science behind DCB outcomes

From Chocolate to Hawk: Vessel preparation for improved outcomes

Live case transmission from Cotignola

Discussion and conclusion

SYMPOSIUM: Going further with drug eluting technology in peripheral arterial disease: From SFA to below the knee challenges.

Opening and learning objectives

Current data and performance of drug eluting technology in SFA

BTK intervention with drug coated balloons. Past lessons and future exploration

Live case transmission from Leipzig

Drug eluting stents in BTK intervention – a review

Next steps in drug eluting stent for BTK intervention

Clinical targets and patient outcome goals in BTK intervention

Panel discussion

Closing remarks

Advanced solutions for calcified lesions and CTOs

Vessel preparation: What does it mean and what are the current tools (PTA, DA and scoring balloons)?

Impact of chronic total occlusion on outcomes: IN.PACT global CTO imaging cohort

Live case transmission from New York

Understanding the challenges with measuring calcium in DCB clinical trials

Vascular calcium: new pre-clinical models and new treatment solutions

Clinical experience with the Phoenix atherectomy system for complex calcified lesions

Applications of Lithoplasty for the treatment of calcified lesions

Shockwave Lithoplasty System treatment of calcified lesions: Intravascular OCT analysis

Live case transmission from Leipzig

The “Crack and Pave” technique for highly resistant calcified lesions: Initial results

Discussion and conclusion

Below-the-knee revascularisation: Current status, challenges, and future outlook

Comprehensive meta-analysis of endovascular versus bypass for critical limb ischemia – is bypass obsolete?

Three-year outcomes of surgical vs. endovascular revascularisation for critical limb ischemia: The Surgical reconstruction vs. Peripheral INtervention in pAtients with critical limb isCHemia (SPINACH) study

Retrograde tibial puncture has changed our algorithm for crossing tibial lesions in CLI: How and when to do it?

Advanced crossing and wiring techniques in BTK vessels

Live case transmission from Leipzig

Technical considerations for successful use of DCBs in BTK arteries: Lessons learned from preclinical studies

Update on the LUTONIX BTK Global Registry: First look at 300 patient interim follow up data

Patterns of vessel calcification in BTK arteries and implications for vessel preparation and atherectomy